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Oh, the butterflies are flying, 
Now the winter days are dying, 
And the primroses are trying 
To be seen. 
And the turtle-doves are cooing, 
And the woods are up and doing, 
For the violets are blue-ing 
In the green. 
 
Oh, the honey-bees are gumming, 
On their little wings, and humming 
That the summer, which is coming, 
Will be fun. 
Ant the cows are almost cooing 
Ant the turtle-doves are mooing, 
Which is why a Pooh is poohing 
In the sun. 
 
For the spring is really springing, 
You can see a skylark singing, 
And the blue-bells, which are ringing, 
Can be heard. 
And the cuckoo isn’t cooing, 
But he’s cucking and he’s ooing, 
And a Pooh is simply poohing 
Like a bird. 
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Fluorescence resonance energy transfer (FRET) is a non-radiative energy transfer from 
a fluorescent donor molecule to an appropriate acceptor molecule and a commonly 
used technique to develop homogeneous assays. If the emission spectrum of the donor 
overlaps with the excitation spectrum of the acceptor, FRET might occur. As a 
consequence, the emission of the donor is decreased and the emission of the acceptor 
(if fluorescent) increased. Furthermore, the distance between the donor and the 
acceptor needs to be short enough, commonly 10-100 Å. Typically, the close proximity 
between the donor and the acceptor is achieved via bioaffinity interactions e.g. 
antibody binding antigen. Large variety of donors and acceptors exist. The selection of 
the donor/acceptor pair should be done not only based on the requirements of FRET 
but also the performance expectancies and the objectives of the application should be 
considered.   
In this study, the exceptional fluorescence properties of the lanthanide chelates were 
employed to develop two novel homogeneous immunoassays: a non-competitive 
hapten (estradiol) assay based on a single binder and a dual-parametric total and free 
PSA assay. In addition, the quenching efficiencies and energy transfer properties of 
various donor/acceptor pairs were studied. The applied donors were either 
europium(III) or terbium(III) chelates; whereas several organic dyes (both fluorescent 
and quenchers) acted as acceptors.  
First, it was shown that if the interaction between the donor/acceptor complexes is of 
high quality (e.g. biotin-streptavidin) the fluorescence of the europium(III) chelate 
could be quenched rather efficiently. Furthermore, the quenching based homogeneous 
non-competitive assay for estradiol had significantly better sensitivity (~67 times) than 
a corresponding homogeneous competitive assay using the same assay components. 
Second, if the acceptors were chosen to emit at the emission minima of the terbium(III) 
chelate, several acceptor emissions could be measured simultaneously without 
significant cross-talk from other acceptors. Based on these results, the appropriate 
acceptors were chosen for the dual-parameter assay. The developed homogeneous 
dual-parameter assay was able to measure both total and free PSA simultaneously 
using a simple mix and measure protocol. Correlation of this assay to a heterogeneous 
single parameter assay was excellent (above 0.99 for both) when spiked human plasma 
samples were used. However, due to the interference of the sample material, the 
obtained concentrations were slightly lower with the homogeneous than the 
heterogeneous assay, especially for the free PSA.  
To conclude, in this work two novel immunoassay principles were developed, which 
both are adaptable to other analytes. However, the hapten assay requires a rather good 
antibody with low dissociation rate and high affinity; whereas the dual-parameter assay 
principle is applicable whenever two immunometric complexes can form 
simultaneously, provided that the requirements of FRET are fulfilled.    
Introduction 
 




Over the years, scientists have strived to develop technologies that could accurately 
and precisely measure large variety of different interesting analytes. Recently, the main 
topic has been how to create simple, fast and reliable assays. Therefore, the emphasis 
has shifted towards homogeneous assays, which are typically easier to do than 
traditional heterogeneous assays. Even though a lot has happened in the world of 
homogeneous assays, they still tend to lag behind heterogeneous assays when 
sensitivity issues are considered.  
One, fairly popular, basis for homogeneous assays is fluorescence resonance energy 
transfer (FRET) from an excited donor molecule to an appropriate acceptor molecule. 
FRET was discovered half a century ago (Förster, 1948) and has slowly gained a high 
status in biotechnology. Currently, the search for “FRET” in the Pubmed database 
results over 2900 hits from various areas such as structural elucidation of biological 
molecules, in vitro assays, in vivo monitoring in cellular research, nucleic acid analysis, 
light harvesting and metallic nanomaterials. Most commonly, the donor/acceptor pairs 
consist of organic dyes. This has, however, slightly limited the attainable performance 
properties of the applications: The short fluorescence lifetime of organic dyes prevents 
the discrimination of autofluorescence during measurement and due to the small 
Stokes’ shift, leakage of the excitation light of the donor into the measurement 
wavelengths is possible. Furthermore, the acceptors might also be excited directly and 
not via energy transfer. (Lakowicz, 1999.)   
Lanthanide chelates were first introduced in 1980’s but the first chelate structures were 
not inherently fluorescent, thus separate enhancement steps were required (Hemmilä, 
1985). Later, intrinsically fluorescent lanthanide chelates were developed, which made 
them viable donors in FRET applications. Lanthanide chelates have unique properties 
that make them superior donors compared to organic dyes. Lanthanide chelates have 
long lifetimes that enable time-resolved measurement of acceptor emission, which 
significantly decreases the effect of autofluorescence and possible direct acceptor 
excitation. Furthermore, their emission peaks are well separated and narrow and their 
Stokes’ shifts are long. (Hemmilä and Laitala, 2005.) Since several different 
lanthanides can be used (mainly europium, terbium, samarium or dysprosium) and they 
all have unique spectral properties, large variety of different acceptors, and hence 
applications, are conceivable.  
In this literature survey, FRET from the viewpoint of lanthanide chelate donors is 
reviewed. The objective is to provide an overview of lanthanides in FRET, the 
appropriate acceptors for them and also what type of assay applications has been 
published. Even though FRET is popular among spectral imaging studies, they are not 
included here. Instead, the emphasis is on different bioaffinity assays applications.  
Review of the Literature 
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2 REVIEW OF THE LITERATURE 
2.1 Terminology of the bioaffinity assays 
Bioaffinity assays are based on the property of biologically active substances to form 
stable, specific and reversible complexes. Common molecular forces such as van der 
Waals or hydrophobic interactions are involved in the formation of these complexes. 
Typically, the complexes used in bioaffinity assays are protein-protein binding (e.g. 
antibody-antigen (protein)), protein-ligand (e.g. streptavidin-biotin) or nucleic acid 
hybridisation. Some of the most commonly used bioaffinity assays are different 
immunoassays, which rely on the unique capabilities of antibodies to recognize and 
bind specific antigens. (Wild, 2005.) 
Bioaffinity assays can be categorized into four different classes; hence, assays are 
either competitive or non-competitive and either homogeneous or heterogeneous. 
Based on the occupancy theory, the difference between the competitive and non-
competitive assays arises from the source of the signal during measurement. If those 
recognizing agents that are bound to the analyte are also the source of the signal, the 
assay is called non-competitive assay. Thus, in non-competitive assay format the 
amount of signal increases with increasing analyte concentration. In competitive 
assays, those recognizing agents that are not bound to the real analyte create the signal. 
Typically, analyte analogue is labelled with some detection probe and creates the 
signal. Therefore, the signal of competitive assays decreases when the analyte 
concentration increases. In practice, competitive assays can be performed using two 
different principles. In back-titration method, first the recognizing agent is let to react 
with the analyte and, thereafter, the labelled analyte is added to react with the still 
available recognizing sites. The other possibility is to create an actual competition 
between the analyte and the labelled analyte by letting them react with the recognizing 
agent simultaneously. Due to the different signal generation methods, the competitive 
and non-competitive assay principles have inherently different sensitivity 
characteristics. It is generally believed that more accurate measurements can be 
attained when small changes are measured in low signal levels than in high signal 
levels. Sensitivity is typically defined as the concentration corresponding a change in 
the signal that can be reliably measured without it being a mere cause of the 
background variation. Since small changes can be measured more reliably in non-
competitive assays (with low signals at zero concentration) than in competitive assays 
(higher signals at zero concentration), the non-competitive assays are typically 
considered to have better sensitivity than competitive assays. (Wild, 2005.) 
In order for the bioaffinity assays to be functional, the assay principle has to be able to 
create a signal that is proportional to the amount of the analyte. Based on this 
fundamental principle, the assays can be classified to be either heterogeneous or 
homogeneous. In heterogeneous assays, the bound label is physically removed from 
Review of the Literature 
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the free label and other interfering factors. This is typically done by using a solid phase 
to collect the sample and then, during a washing step, remove all the interfering factors 
away before measurement. Homogeneous assays do not have any separation steps, thus 
the binding reaction of the analyte or labelled analyte has to cause some measurable 
change in the signal level to create the correlation between analyte concentration and 
signal. This change may occur via various methods for example using environmentally 
sensitive labels, changes in fluorescence polarization or utilizing fluorescence 
resonance energy transfer. Since homogeneous assays do not have any separation steps 
that could cause variations in the signal levels, in theory, they should have better 
sensitivity than heterogeneous assays. However, in reality this is hardly ever the case 
since the presence of the sample material tends to interfere with the measurement and, 
thus, impair the overall sensitivity. (Wild, 2005.) Despite the sample interference 
issues, the homogeneous assays are typically easy to perform (ideally: mix and 
measure) and automate. Therefore, the homogeneous assays are gaining popularity in 
applications were the number of samples is large and/or the speed of the assay is 
important.         
2.2 Introduction to fluorescence resonance energy transfer 
2.2.1 Luminescence 
Luminescence (emission of light that occurs from electronically excited states) is the 
phenomenon underlying the development of FRET based techniques. It can be divided 
into several categories depending on the energy source used for the excitation of the 
luminescent molecule. Chemiluminescence is a technique where the measured light is 
generated during a chemical reaction. Since no external excitation is required, the 
background luminescence is small. Thus, the chemiluminescence-based assays can 
theoretically have excellent sensitivities. (Wild, 2005.) When the light emitting 
reaction is catalysed by enzymes, like luciferase, bioluminescence is said to happen. 
(For recent review see Prinz et al., 2008, Bacart et al., 2008.) Luminescence is called 
radioluminescence if the exciting energy comes from radiative entities emitted by 
radioactive particles. (For example Erfurt and Krbetschek, 2002, Nowotny, 2007, Blair 
et al., 2006.) Electroluminescence occurs when the excitation energy is obtained from 
electric current. (For recent review see Chen et al., 2004, Godlewski, 2005, Bandaru, 
2007.) Finally, luminescence can originate from a directly luminescent label molecule 
that can be conjugated to the assay components. There are enormous amounts of 
different label molecules. (Wild, 2005.) This thesis concentrates on lanthanides as 
directly fluorescent labels and their applications in the field of fluorescence and energy 
transfer.   
Luminescence can also be divided into two categories based on the lifetime of the 
luminescence. When a photoluminescent molecule absorbs light, its electrons are 
raised from the lowest energy level to some of the excited levels. The dispersal of the 
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energy back to the ground state may occur via non-radiative processes to produce heat, 
or the molecule might transfer the energy to another molecule. When the absorbed 
energy is dissipated in the form of an emitted photon, the phenomenon is called 
fluorescence or phosphorescence. (Hemmilä, 1991.) The lifetime of fluorescence is 
typically near 10 ns; whereas the lifetime of phosphorescence is longer, from 
milliseconds to seconds. Lifetime of the luminescence is the time at which the intensity 
of the signal decreases to 1/e of its initial value. Lifetime is also the average amount of 
time a fluorophore remains in the excited state after the excitation. (Lakowicz, 1999.)  
The events during the excitation and the following emission can be presented using a 
Jablonski diagram. (Figure 1) 
Figure 1 Energy flow diagram (Jablonski diagram) for a fluorescent and phosphorescent 
component (Hemmilä, 1991). 
When a molecule absorbs light, one of its electrons from the occupied orbital is 
promoted to an unoccupied orbital. The absorbed energy is discharged rapidly to the 
lowest level of singlet by vibrational relaxation (VR) and in the case of higher excited 
singlets (S2 =>), to the lowest excited singlet (S1) by internal conversion (IC). The 
actual fluorescence occurs from the lowest vibrational sublevel of the S1 level and the 
electron can return to any of the vibrational levels of ground state (Figure 1). Because 
the emission always happens from the lowest excited level, the used excitation 
wavelength does not affect the shape of the emission spectrum. In some cases, a 
singlet-triplet (T1) intersystem crossing (ISC) might occur in which case the excited 
emission is called phosphorescence. This transfer is an unlikely process but some 
phosphorescent compounds exist.  (Hemmilä, 1991.) As can be seen in the figure 1, the 
energy of the emission is typically lower than the energy of the absorption. Therefore, 
fluorescence usually occurs at lower energies or longer wavelengths than absorption.  
Review of the Literature 
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2.2.2 Principles and requirements of FRET 
Fluorescence resonance energy transfer (sometimes called Förster resonance energy 
transfer, FRET) can be defined as a non-radiative energy transfer from an excited 
donor molecule to an acceptor molecule (Selvin et al., 1994). Due to FRET, the 
intensity of the donor fluorescence decreases. The acceptor can be fluorescent or non-
fluorescent molecule. Based on the donor and the acceptor molecules, two categories 
of FRET can be identified: Heterotransfer occurs between two chemically different 
molecules, thus donor and acceptor are distinctively different molecules. If the Stokes’ 
shift of the molecule is small, FRET can also occur between two chemically identical 
molecules, which is called homotransfer. (Lackowicz, 1999.) In order FRET to occur, 
spectral overlapping of the donor and the acceptor, close enough proximity and dipole-
dipole angels other than 90 degrees are required. The requirement of the overlapping of 
the donor emission spectrum with the excitation spectrum of the acceptor is commonly 
called the Förster principle (Förster, 1948, Figure 2). 
Figure 2 Schematic picture of the Förster principle. The emission spectrum of the donor 
(straight line) overlaps well with the excitation spectrum of the acceptor 1 (dotted line), thus 
FRET could occur; whereas, there is no overlapping with the excitation spectrum of the 
acceptor 2 (dashed line). In this case, no FRET could occur.  
From the spectral overlapping, the theoretical intensity of FRET between a specific 
donor-acceptor pair can be estimated with Förster radius or distance (R0) (Förster, 
1948). Förster radius is the distance of the donor and the acceptor when the efficiency 
of the energy transfer is 50% from the maximum value and can be calculated using 
equation: 
( )[ ] 6/1420 211.0 λκ JQnR D−=                                                                                      (1) 
 
Where n is the refractive index of the medium (typically ~1.4 for aqueous solutions), 
QD is the quantum yield of the donor in the absence of the acceptor and J(λ) is the 
spectral overlapping of the donor-acceptor pair (figure 2). The κ2 is a factor describing 
the relative orientation in space of the transition dipoles and the acceptor (usually 
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assumed to be equal to 2/3). (Lakowicz, 1999.) The quantum yield can be 
environmentally sensitive, thus the R0 values for a D-A pair can vary if the solution 
conditions change. Also the spectral properties of the donor or acceptor may change 
due to environmental factors. (Wu and Brand, 1994.) For example, presence of certain 
metal ions can shift the absorption maximum of the acceptor and thus either allow or 
prohibit FRET. These properties have been used to create FRET based metal ion 
assays, so called FRET on-off or off-on assays. (Lee et al., 2007, Lee et al., 2008.) 
Typically, donor-acceptor pairs that have R0 between 20-90 Å are used to study 
biological macromolecules (Lakowicz, 1999). However, if the donor and the acceptor 
are chosen appropriately, pairs with R0 under 10 Å can be used to study smaller 
molecules (Sahoo et al., 2006, Sahoo et al., 2007). 
The electron cloud of a molecule has a limited volume. Typically, the interactions of 
the molecule are limited to this volume. However, some molecules can interact with 
other molecules at much greater distances by projecting an electromagnetic field, 
which exists in a molecule if the molecule has one region with net positive charge and 
other with net negative charge. This charge difference creates a dipole. If the molecule 
is asymmetric, these fields typically have a specific orientation. In FRET, the 
excitation light induces an oscillating field in the donor. Thereafter, this oscillating 
emission dipole can influence the absorption dipole of the acceptor to oscillate in 
synchrony. If the emission dipole of the donor is in 90 degrees angle to the absorption 
dipole of the acceptor, the oscillations will cancel each other out, thus no FRET can 
occur. Therefore, FRET requires that the dipole-dipole angles are not perpendicular to 
each other. (Vogel et al., 2006, Lakowicz, 1999.)  It has also been shown that the 
coupling responsible for FRET generates a mechanical force between the D-A-pair that 
is distinct from the typical van der Waals force between ground state molecules. This 
underlying potential is also depended of the distance of the donor and the acceptor. 
(Cohen and Mukamel, 2003.) 
Finally, FRET can occur only if the donor and the acceptor are close enough proximity 
to each other. Typically, the distance should be 10-100 Å (Lakowicz, 1999). The rate 













                                                                                                            (2)   
 
Where the τD is the decay time of the donor in the absence of the acceptor and r is the 
distance between the donor and the acceptor. (Lakowicz, 1999.) The strong 
dependence between the rate of FRET and the distance of the D-A-pair makes FRET a 
feasible technique to study average distances between donor and acceptor. However, 
there are some shortcomings with using FRET to measure average distances. First, all 
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the distances are determined in reference to the Förster distance, which is a theoretical 
value calculated from the spectral properties of the D-A pair (Wu and Brand, 1994). 
Second, the orientation factor (κ2) needed for the R0 calculations embodies some 
uncertainties. The orientation factor can differ from 0 to 4 (value of 2/3 is typically 
used) and at the moment, there are no means to measure the value exactly, thus the 
results from the distance measurements may deviate from the true distance. (Lakowicz, 
1999.) These uncertainties can be reduced by, for example, utilizing fluorescence 
polarization anisotropy measurements to study the feasible upper and lower limits of 
the orientation factor (Dale et al., 1979) or by using time resolved decay studies to 
measure distributions of the defined distance (Wu and Brand, 1992). However, it has 
been shown that when the κ2 value of 2/3 is used, the maximum error in the calculated 
distance is 35%, thus reasonably accurate results can be obtained (Lakowicz, 1999). 
Furthermore, these calculations usually assume that κ2 and r are independent of each 
other. However, in some cases, for example when the other probe is free and the other 
is fixed, these values might be dependent (VanBeek et al., 2007). Thus, assumptions of 
independence should be considered before calculations. 
To conclude, the range of distances available between donor and acceptor and the 
efficiency of FRET are regulated by the spectral properties of the D-A pair. The 
molecular processes occurring during FRET are presented in Jablonski diagram in 
figure 3. 
Figure 3 Simplified Jablonski diagram of the FRET process (Lakowicz, 1999). 
First, the excitation of the donor occurs as described earlier. If an appropriate acceptor 
is nearby and the other requirements of FRET are realized, a non-radiative energy 
transfer from donor to acceptor may occur (kfret = the efficiency of the energy transfer). 
If the acceptor is a fluorescent molecule, acceptor emission may result. As can be seen 
from figure 3, the process of FRET does not involve any intermediate photons. Instead, 
the energy transfer is based on a theory of fluorophore as an oscillating dipole, which 
can exchange energy with another dipole with a similar resonance frequency. 
(Lakowicz, 1999.)  
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2.2.3 FRET measurements 
When the emission of a fluorophore (donor or acceptor) is measured, two fundamental 
methods can be distinguished: steady-state and time-resolved (TR) measurements. In 
steady-state measurements the fluorophore is excited with a continuous beam of light 
and the intensity of the emission is measured. This is the most common type of 
fluorescence measurement. In TR measurements, the fluorophore is exposed to pulsed 
excitation light, where the pulse width is shorter than the decay time of the fluorophore 
emission. Between excitation and measurement of the emission, a short time is waited, 
during which the possible background fluorescence of the sample components and 
autofluorescence of other interfering materials is decreased. Thus, the measurement is 
more specific to fluorophore emission than the steady-state measurements. However, 
TR measurements require that the lifetime of the fluorophore emission is long enough 
and also somewhat sophisticated instrumentation, thus these measurements are not as 
common as the steady-state measurements. (Lakowicz, 1999.) The occurring FRET 
can be measured using number of different methods. Essentially, the methods can be 
divided into four basic principles: measurements of changes in donor emission, 
acceptor emission, both donor and acceptor emission simultaneously (Figure 4) or 
orientation of the fluorophores. 
Figure 4 Schematic figures of the emission changes underlying the FRET measurements. Solid 
line: no FRET and dashed line: FRET situation. Left: If FRET occurs, the emission of the 
donor decreases and the emission of the acceptor increases (if fluorescent). Right: As a result of 
FRET the lifetime of the donor emission is decreased. (Modified from Vogel et al., 2006.) 
The measurements of the changes in the donor emission are typically done by either 
lifetime or fluorescence intensity (quenching) measurements. In the quenching 
measurements, the intensity of the donor emission is measured in the presence and 
absence of the acceptor. If FRET occurs the emission of the donor is decreased, which 
can be quantified. The measurement wavelength is selected in a way that the possible 
acceptor emission does not contribute to the measurement. (Wu and Brand, 1994.) As a 
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result of FRET, also the fluorescence lifetime of the donor shortens, which can be 
measured (Ozinskas et al., 1993). The efficiency of energy transfer (E) in quenching 










−= 1                                                                  (3, 4) 
 
Where the FDA and FD are the fluorescence of the donor and τDA and τD the fluorescence 
lifetimes of the donor in the presence (DA) and absence (D) of the acceptor. 
(Lakowicz, 1999.) However, it has been shown that the efficiency cannot be 
determined accurately, unless the sample contains only D-A complexes (no free donors 
or acceptors). Furthermore, all the complexes need to be perfectly labelled. 
(Wlodarczyk et al., 2008.) In addition, three things need to be considered when donor 
emission changes are measured. A) If the donor is conjugated to a large molecule and 
the acceptor functions as a ligand, the binding of the ligand/acceptor might cause 
changes in the fluorescence properties of the donor through conformational changes of 
the large molecule. If this happens, it should be noticed in the efficiency calculations. 
B) If the acceptor absorbs at the wavelength of the donor excitation, it might cause 
some inner filtering, thus decreasing the observed donor emission. It can be corrected 
using absorbance measurements. C) Intermolecular energy transfer may occur if the 
acceptor concentration is very high. The critical concentration of the acceptor, in which 
the energy transfer is 76%, can be calculated (as moles per liter) from: 447/R03, where 
R0  is the Förster distance in Ångströms. However, the acceptor concentration should 
be much lower than that because when the acceptor concentration exceeds on 
hundredth of the critical concentration, possibility of intermolecular energy transfer 
exists. (Wu and Brand, 1994, Lakowicz, 1999.)    
If the acceptor is a fluorescent molecule then one possibility to measure FRET is to 
monitor the changes in the acceptor emission (also called sensitized emission) as a 
result of donor excitation. The sensitized emission can be measured both with steady-
state and time-resolved methods. For both of the methods, it is important to ensure that 
no donor emission leaks through the acceptor emission filter and alters the results. 
(Gordon et al., 1998.) Furthermore, if the absorption spectra of the acceptors overlap 
with the excitation wavelength, the acceptor might be directly excited without any 
FRET (Vogel et al., 2006). Thus the measurement conditions need to be carefully 
considered. In addition, if a large molecule (e.g. antibody) is labelled with multiple 
acceptors, the proximity of the acceptors might cause energy transfer between 
acceptors (if the absorption and emission spectra of the acceptor overlap substantially) 
and the observed sensitized emission decreases from the true levels (Miller, 2005). 
Sometimes it is convenient to measure both donor and acceptor emissions 
simultaneously. In immunoassays, this double-wavelength detection enables real-time 
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correction for optical transmission making the assay free from media interactions 
(Mathis, 1995). Also, some applications of the spectral imaging microscopy utilize the 
simultaneous measurement of both donor and acceptor emissions. These techniques 
can be used to measure the efficiency of FRET as well as the abundance of the donors 
and acceptors. For a recent review see for example Sekar and Periasamy, 2003, Jares-
Erijman and Jovin, 2003. 
Also fluorescence polarization anisotropy can be used to measure FRET. These 
methods compare the orientation of the molecules excited with the orientation of the 
molecules that emit photons using linearly polarized light. If no FRET occurs then the 
same molecule is excited and emits the light, thus its orientation will be highly 
correlated. If FRET, however, occurs then the emitting molecule might be different 
than the excited molecule and, thus, correlation between their orientations will 
decrease. (Vogel et al., 2006.) 
To conclude, the efficiency of FRET can be measured using several different 
approaches. However, the evaluation of the accuracy of FRET measurements is 
challenging. This is mainly due to the fact that there are no widely accepted FRET 
standards (molecules with known FRET efficiencies), against which different methods 
could be compared. Furthermore, the FRET results are, in many cases, presented using 
indices (relative measures) instead of the actual efficiency values. These indices 
methods typically vary between different applications. (Berney and Danuser, 2003.) 
Therefore, Vogel et al. suggest that, if possible, indices should be avoided and FRET 
efficiencies should be used (Vogel et al., 2006). 
2.3 Lanthanide chelates as donors in FRET 
The first successful lanthanide chelate technology was published during the 1980’s. 
These chelates required dissociative fluorescent enhancement step to convert a non-
fluorescent chelate into a highly fluorescent one. This was also commercialised as a 
DELFIA (Dissociation Enhanced Lanthanide FluoroImmunoAssay) system by Wallac, 
currently part of Perkin Elmer Life and Analytical Science. (Soini and Kojola, 1983, 
Mukkala et al., 1989.) From those days, also directly (intrinsically) fluorescent 
lanthanide chelates that do not require enhancement steps have been developed. These 
lanthanide chelates (mainly europium, terbium, samarium and dysprosium) have many 
beneficial fluorescence characters that make them ideal candidates for donors in FRET. 
Only the intrinsically fluorescent chelates can act as donors, thus only they are 
reviewed in this thesis. For a recent review of the other chelate technology see for 
example Hemmilä and Mukkala, 2001. It should be noted that the precise term for the 
energy transfer, when lanthanides are used as donors, is luminescence resonance 
energy transfer (LRET), since the lanthanide emission is not, technically, considered to 
be fluorescence. However, LRET obeys the same previously described principles as 
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FRET. Nonetheless, term FRET is very commonly used in the literature with 
lanthanides and, thus, is also used throughout this thesis.  
2.3.1 Structure of lanthanide chelates 
In order to be a functional label, the candidate molecule has to fulfil certain 
requirements. It has to be stable and soluble. For the labelling reactions to other 
molecules, such as antibodies, the molecule has to be small and hydrophilic, preferably 
with a negative net charge to avoid decreased solubility and increased non-specific 
interactions of the conjugate (Hemmilä et al., 1997). Furthermore, the binding of the 
label to the antibody or antigen should not have negative influence to their properties. 
In addition, a high luminescent intensity is required for a sensitive detection (Hemmilä, 
1985). Lanthanide ions cannot fulfil these requirements alone. However, when 
combined with an organic chromophore (called antenna or sensitizer), which absorbs 
the excitation light and transfers it to the lanthanide ion, powerful fluorescent probes 
can be developed (Selvin, 2002). For efficient energy transfer, the organic 
choromophore and the lanthanide ion need to be in close proximity to each other 
(Hemmilä et al., 1997). The most commonly used antennas are based on pyridine, 
bipyridine, terpyridine, salicylate, coumarin derivatives, phenanthroline and pyrazole 
derivatives (Hemmilä and Laitala, 2005). The ligand binds to the lanthanide ion tightly 
and shields the lanthanide ion from the quenching effects of water. The fluorophore 
also includes some reactive group that can be used to conjugate the complex to 
biomolecules (Selvin, 2002). Some of the typical intrinsically fluorescent lanthanide 









Figure 5 Some representatives of different chelate structures I: nona-dentate pyridine based 
europium chelate (von Lode et al., 2003) II: polyaminocarboxylate terbium chelate (Selvin and 
Hearst, 1994) III: europium  tris-bipyridine cryptate (Bazin et al., 2001). 
As can be seen from the figure 5, in the pyridine and cryptate based probes (I, III) the 
antenna participates to the binding of the lanthanide ion; whereas, in the 
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entities (Selvin, 2002). Pyridines are the most commonly used light-absorbing aromatic 
groups in lanthanide chelates. However, the pyridine based lanthanide probes are 
susceptible to the quenching of water molecules because they have a strong tendency 
to fill their first coordination sphere with water molecules up to the coordination 
number nine. Therefore, increasing the number of coordinating groups with the metal 
ion can enhance the stability of the chelates. Furthermore, the water solubility can be 
attained with sugar moieties in the chelate structure. (von Lode et al., 2003.) Terbium 
does not necessarily form fluorescent chelates with same ligands as used for europium. 
Therefore, for terbium, one or two of the pyridines are often substituted with five-
member rings, such as pyrazole, imidazole or thiazole. (Hemmilä and Mukkala, 2001.) 
The cryptates are a cage like chelates where the ions are encapsulated inside the cavity 
and are, therefore, highly inert and can be used under drastic chemical conditions, for 
example in acidic media (Bazin et al., 2001).  The polyaminocarboxylate chelates have 
a tendency to bind the lanthanide ion extremely tightly (Selvin and Hearst, 1994). In 
conclusion, the fluorescent lanthanide chelates can be constructed using numerous 
different building blocks. In the end, stable and highly fluorescent probes should be 
attained. 
2.3.2 Fluorescence properties of lanthanide chelates 
The lanthanides are fluorescent metals, which display emission in aqueous solutions 
and decay times of 0.5-3 ms. The absorption coefficients of lanthanides are very low 
and the emission rates are slow, which results in long lifetimes. Due to the weak 
absorption, this luminescence is observed only at high lanthanide concentrations or 
when excited directly by lasers. (Leonard and Gunnlaugsson, 2005.)  However, these 
shortcomings can be avoided by using an organic antenna as an energy transfer moiety 
(Lakowicz, 1999). The most used lanthanides are terbium and europium, which emit at 
the visible wavelengths. Also samarium and dysprosium emit at visible but their 
fluorescence intensity is weaker; thus, they are less common than europium and 
terbium. (Xu et al., 1992.) The Jablonski diagram for lanthanide chelate (using terbium 
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Figure 6 Simplified Jablonski diagram for the fluorescence process in a terbium chelate 
(Lakowicz, 1999). 
The lanthanide excitation is a two-step process. First, the antenna is excited in the 
ultraviolet wavelengths. Second, the energy is transferred through an intramolecular 
energy-transfer process to the lanthanide ion. Thereafter, the excited lanthanide may 
express luminescence. The lanthanide ions have several ground states and the transition 
distribution to these ground states (7Fx in figure 6) creates the ion- and chelate specific 
emission profiles. (Hemmilä and Laitala, 2005.) (Figure 7) Due to the chelate structure 
that shields the lanthanides from the broadening effects of the solvent, the emission is 
typically narrow-band line-type emission (the emission peaks are narrow and well 
defined), whereas the excitation region is typically large (Selvin, 2002). The multitude 
of well separated emission peaks enables the viability of lanthanide chelates in 
heterogeneous multi-parameter assays (Hemmilä and Mukkala, 2001) and recently also 
in homogeneous assays (Karvinen et al., 2004a, Kupcho et al., 2007, Jeyakumar and 
Katzenellenbogen, 2009). Since the excitation wavelengths are ultraviolet and the 
emissions are visible, the Stokes’ shift of the lanthanide chelates are large (> 250 nm), 
which facilitates the emission measurement without interference from the excitation. In 
addition, the lifetime of the luminescence of the lanthanide chelates is exceptionally 
long; thus enabling time-resolved measurements  (Hemmilä, 1985). The fluorescence is 
also unpolarized, which reduces the previously described orientation dependency of 
FRET and makes the distance determinations more accurate (Selvin, 2000). The 
lanthanide chelates do not suffer from self-quenching, thus they can be packed inside a 
nanoparticle without degrading the fluorescence properties of the probe. These 
particulate labels are typically latex or silica-based. (Hemmilä and Laitala, 2005.) 
Furthermore, the shell protects the lanthanide chelates inside the particle from 
interferences, such as water molecules or metal ions (Ye et al., 2004, Kokko et al., 
2007).  
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Figure 7 Left: The normalized emission spectra of Eu(III), Tb(III), Sm(III) and Dy(III) 
chelates. (Modified from Huhtinen et al., 2005.) Right: The major emission lines for the 
lanthanide chelates. The dominant peak in bold. (Hemmilä, 1991.)  
The previously described europium, terbium, samarium and dysprosium chelates are 
so-called down-converting probes; the emission occurs at longer wavelengths than the 
excitation. Some lanthanides, mainly erbium, thulium, praseodymium, holmium and 
ytterbium, can also be used to create up-converting probes, where the excitation occurs 
at the infrared area and emission at visible wavelengths. These systems are free of 
background interferences because up-conversion does not occur in the nature. 
However, these probes are not based on chelate structures; instead they are inorganic 
particles that consist a crystalline host lattice doped with rare earth lanthanide ions. For 
a recent review see Soukka et al., 2005  Soukka et al., 2008. 
2.3.3 Other long lifetime fluorescent probes 
Lanthanides are not the only metals that can be used to create a long lifetime 
fluorescent probes. Also transition-metal-ligand complexes and metallo-porphyrins can 
be utilized. The transition-metal-ligand complexes are typically based on ruthenium, 
rhenium or osmium with one or more diimine ligands. These complexes are highly 
stable, so the metals do not dissociate from the ligands significantly. (Lakowicz, 1999.) 
The metallo-porphyrins are typically complexes of platinum or palladium. Particularly 
platinum is used due to a higher quantum yield in aqueous solutions and room 
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Figure 8 Left: Ruthenium-ligand complex (Terpetschnig et al., 1995) and Right: platinum 
porphyrin (de Haas et al., 1997). 
The luminescence process of the transition-metal-ligand complexes is reversed 
compared to the lanthanide chelates; the energy transfers from the metal ion to the 
ligand. This is partially forbidden, thus the lifetimes of the complexes are long (10 ns 
to 10 µs). (Lakowicz, 1999.) Both the transition-metal and porphyrin complexes 
display large Stokes’ shift (Lakowicz, 1999, Eastwood and Gouterman, 1970). The 
emission spectra of the transition-metal-ligand complexes consist of a one large peak 
where the wavelength of the emission maxima can be changed by using different metal 
ions or ligands (Kober et al., 1985, Terpetschnig et al., 1995). The emission peaks of 
porphyrin complexes are narrower but contain typically only one peak (Eastwood and 
Gouterman, 1970, de Haas et al., 1999).   
2.4 Acceptors in FRET 
Numerous different acceptors are available. The decision which acceptors are to be 
used is made based on the properties of the donor and the performance expectations of 
the application. In this thesis, only acceptors that absorb and emit (if fluorescent) at 
visible or near IR area, and are thus suitable for lanthanide chelate donors, are 
reviewed. For a more complete review of the various acceptors see for example 
Sapsford et al., 2006. 
2.4.1 Organic dyes 
Organic dyes (either fluorescent or non-fluorescent) are the most commonly used 
acceptors in FRET. In fact, they are usually utilized both as donor and acceptor; 
typically as pairs of coumarin/fluorescein, fluorescein/rhodamine and Cy3.5/Cy5 or 
their derivatives. (Massey et al., 2006.) Structures of some of the organic dyes are 
presented in figure 9. Due to the high number of cyclic structures, the dyes tend to be 
hydrophobic. This can be problematic when conjugating these dyes to other molecules, 
thus also more hydrophilic dyes have been developed (Zheng et al., 2007). 
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Figure 9 Structures of common acceptors: fluorescent dyes fluorescein (I) and rhodamine (II) 
and a non-fluorescent dye family of QSY (III) (Sapsford et al., 2006). 
A wide variety of different emission maxima can be obtained by using different dyes 
(figure 10); thus these dyes can be used as acceptors with numerous donors and 
applications. Organic dyes typically have a short fluorescence lifetime together with 
broad absorption and emission spectra and, thus, small Stokes’ shifts. (Lakowicz, 
1999.) This could cause excitation light to leak to the emission measurement results 
and self-quenching (Sapsford et al., 2006). However, the lanthanide donors extend the 
lifetime of the fluorescence of the organic dyes; hence a time resolved measurement of 
the sensitized emission could be used. This prevents the leakage of the excitation light 
and possible background fluorescence not originating from FRET (Selvin, 2002). To 
avoid self-quenching, appropriate distance between organic dyes (for example when 
proteins are labelled) is required (Lakowicz, 1999). The organic dyes can also be 
environmentally sensitive. When near IR dyes were studied, it was noticed that some 
of the emission maxima shifted and lifetimes changed due to ethanol or detergent 
additions. Furthermore, when the dyes were conjugated to biotin and streptavidin was 
added, a clear change in the spectral properties of both the dye-biotin and dye-biotin-
streptavidin complexes were observed compared to free dyes. (Buschmann et al., 
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Considerable numbers of different acceptors have been developed and are 
commercially available. These commercial dyes are easy to use since they typically are 
in a reactive form and can be conjugated directly to various molecules through 
different reactive moieties. Some of the most common acceptors and their 
manufacturers are presented in figure 10 together with their feasible emission 
wavelengths for fluorescent acceptors and absorption wavelengths for the non-
fluorescent acceptors (quenchers). 
Figure 10 Some of the most common commercially available organic dyes and their emission 
wavelengths (for fluorescent dyes) and absorption wavelengths (for quenchers). The Alexa 
Fluor, BODIPY, Dabcyl and QSY –series are sold by Molecular Probes, Invitrogen. Cy –series 
is a product of GE Healthcare. Hilyte Fluors and QXL quenchers are manufactured by 
AnaSpec. Oyster dyes are products of Denovo biolabels. Bioresearch manufactures Black hole 
quencher and the CAL Fluors and Quasar dyes. Atto dyes and quenchers are products of Atto-
Tec and Blackberry comes from Berry and Associates.  
In principle, the signal levels of an assay could be increased by using multiple 
fluorophores as donors and/or acceptors. However, excess labelling might change the 
function of the molecule. Furthermore, with organic dyes the self-quenching inhibits 
high labelling degrees. Therefore, fluorescent nano- and microparticles soaked with 
fluorophores have been developed. (Sapsford et al., 2006.) In addition, these particles 
can be doped with varying amounts of different organic dyes simultaneously and, thus, 
different colours can be exhibited using only one excitation wavelength, technique 
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called barcoding (Wang and Tan, 2006). Commercially available TransFluospheres 
(TFS) are particles that contain optimal combination of dyes in order to optimise the 
internal FRET and also to yield large Stokes’ shift (Molecular Probes, Invitrogen). 
2.4.2 Proteins as acceptors 
Fluorescent proteins, mainly phycobiliprotein family or green fluorescent protein and 
its derivatives, are used intensively as donors and acceptors in various FRET 
applications, mainly in diverse imaging techniques. However, they also have spectral 
properties that enable them to be used as acceptors for lanthanide chelates as well.  
The most commonly used phycobiliproteins are B- and R-phycoerythrins (B- and R-
PE) together with allophycocyanin (APC). These proteins are found in cyanobacteria 
and red algae. The subunit structure of B- and R-phycoerythrins [(αβ)6γ] is extremely 
stable (Oi et al., 1982), whereas the trimer structure [(αβ)3] of APC tends to dissociate 
at low concentrations. Therefore, more stable, cross-linked APC, has been developed 
(Yeh et al., 1987). The spectral properties of R-PE and APC are presented in figure 11. 
Figure 11 Absorption (dashed line) and emission (solid line) spectra of R-PE and APC 
(Obtained from Molecular Probes,  Invitrogen).  
It has been shown that the quantum yields of the emission of the phycobiliproteins are 
wavelength-independent, thus they can be excited using large variety of excitation 
wavelengths (Yeh et al., 1987). Therefore, they can have somewhat large Stokes’ 
shifts, even though their absorption and emission maxima are in close proximity. They 
also have high quantum yields. Furthermore, phycobiliproteins are water-soluble and 
stable, thus they endure long storage time. (Lakowicz, 1999.) In addition, their spectral 
properties make them good candidates to act as acceptors for lanthanide chelates.  
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The green fluorescent protein (GFP) was discovered by Osamu Shimomura in 1960’s 
from jellyfish Aequorea Victoria and has since, together with its derivatives (blue, cyan 
and yellow fluorescent proteins), became one of the most powerful imaging techniques 
used in fluorescence based optical microscopy (Nienhaus, 2008). Furthermore, in the 
year 2008 Osamu Shimomura, Martin Chalfie and Roger Tsien won the Nobel price for 
the discovery and development of the GFP. The GFP has 238 amino acids that fold into 
a rigid 11 stranded β barrels with a central helix running along its axis (Tsien, 1998). 
The fluorescent group is situated within a highly constrained and protected region of 
the protein (Lakowicz, 1999). GFP can be co-expressed with other proteins 
intracellularly and when visualized, reveal the location and relative expression level 
(Sapsford et al., 2006). GFP has an absorption maximum at 395 nm and a shoulder at 
470 nm. Maximum emission occurs at 509 nm. (Chalfie et al., 1994.) Thus, GFP could 
be a suitable acceptor for at least terbium chelates (Riddle et. al., 2006). For a review 
of the spectral properties of other fluorescent proteins, see for example Shaner et al., 
2007. 
2.4.3 Quantum dots as acceptors for lanthanide chelates 
The previously presented organic dyes and fluorescent proteins are the most commonly 
used acceptors for lanthanide chelates. However, some other probes have also spectral 
properties that enable them to be used as acceptors.  
Quantum dots are nanocrystal fluorophores that consist of a semiconductor core 
followed by a semiconductor layer and have variable surface layers depending on 
needed surface functionalization. The core is typically composed of elements from the 
groups II and IV (cadmium/selenium being the most common combination) or groups 
III and V (for example indium/phosphorus). The second semiconducting layer is made 
of material that has a larger band gap than the core semiconductor, such as 
zinc/sulphur. Finally the surface layer is structured to make the dots water-soluble and 
also compatible for different bio-conjugations. (Alivisatos et al., 2005.) Quantum dots 
have very wide absorption spectra, thus several excitation wavelengths can be used. 
Whereas, the emission spectra is narrow and the emission wavelength can be 
controlled by changing the core size or composition of the dot. (Jamieson et al., 2007.) 
Therefore, quantum dots can be engineered to emit light at a variety of precise 
wavelengths typically ranging from 450 nm to 850 nm (Yezhelyev et al., 2006). Thus, 
quantum dots could potentially be used to create multi-parameter assays where with 
one excitation wavelength several different emission wavelengths are achieved.  
2.5 Applications of FRET using lanthanides as donors 
The number of published FRET applications is enormous. Most commonly the D-A 
pairs are consisted of organic dyes. However, lanthanide chelates have been used in 
various applications. The emphasis of this chapter is to present different assay 
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techniques together with diverse lanthanide-acceptor pairs, in order to show the 
versatility and possibilities of the lanthanide chelates as donors in FRET based assays. 
All of the presented techniques are based on exploiting the beneficial characters of the 
lanthanide chelates (more detailed descriptions previously): The long lifetime of the 
lanthanides extends the lifetime of the sensitized emission of the acceptors, thus 
enabling time-resolved measurement of the emission. In addition, the long Stokes’ shift 
diminishes leak of the excitation light to the measurement and the sharp emission 
peaks alongside with the emission valleys provide several appropriate wavelength 
areas for designing FRET assays with small contribution of the donor emission to the 
background signal. The basic principles of some of the FRET based assays are 
presented in figure 12.  
Figure 12 The underlying main principles of the published FRET based assays utilizing 
lanthanides as donors. I: Homogeneous sandwich assay, which uses a donor (D) and acceptor  
(A) labelled moieties (R11 and R2) that can recognize the analyte. FRET can occur if both of the 
recognizing agents are bound to the analyte (An). II: In competitive assay format, the analyte 
competes of the recognizing moiety with the acceptor labelled analyte analogue. Thus 
increasing analyte concentration decreases the obtained signal. III: In DNA-hybridisation 
assays, FRET can occur if both the donor and the acceptor oligonucleotides are hybridised to 
the target DNA. IV: In the protease/nuclease activity assays, FRET can typically occur in the 
absence of the active enzyme. In the presence of the enzyme (Enz.) the substrate is cleaved 
between the donor-acceptor pair and, thus, the distance is too long for efficient FRET to occur.  
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Perhaps the simplest homogeneous assay principle is based on the traditional 
heterogeneous sandwich immunoassay. In the homogeneous version, one of the 
antibodies is labelled with the donor and the other with the acceptor. FRET can occur 
when both of the antibodies are bound to the antigen (Figure 12, I). This technique has 
been used to create an immunoassay for the β subunit of human chorionic 
gonadotropin (βhCG) utilizing terbium chelate as a donor and rhodamine as an 
acceptor. The obtained performance of the assay correlated well with a conventional 
heterogeneous immunoassay. In that study, it was also shown that homogeneous assays 
do not require shaking of the plates, which simplifies the assay protocols even further. 
(Blomberg et al., 1999.) One of the main disadvantages in the homogeneous assays is 
the possible sample interference during measurement. It was shown; with a sandwich 
assay using europium cryptate as a donor and APC as an acceptor that by using the 
proportion of two measurement wavelengths, one at the donor emission and one at the 
acceptor emission, the interference of the sample could be reduced and the 
performance of the assay was significantly improved. Even with human serum 
samples, the results of the homogeneous assay correlated well with a heterogeneous 
radioimmunoassay (RIA).  (Mathis, 1993.) Recently, also terbium cryptates have been 
used in homogeneous assays. For example, Leifert et. al have used terbium cryptate as 
a donor and Alexa Fluor 546 as an acceptor while studying the G-protein subunit 
interactions (Leifert et al., 2006). Particulate labels can also be used to design 
homogeneous sandwich assays. Valanne et. al used a europium particle as donor and 
TFS particle as an acceptor to design a homogeneous PSA assay. With this protocol, a 
good sensitivity of ~0.1 ng/mL was obtained. However, the dynamic range was 
somewhat low since the signal levels started to decrease after 25 ng/mL. (Valanne et 
al., 2005.) Particulate labels have high donor density, thus several chelates can 
participate to the energy transfer. Therefore, in these cases, the sensitized emission of 
the acceptor can be very high, sometimes even high enough for the detection of FRET 
at the single-nanoparticle level (Casanova et al., 2006). As described previously, the 
emission spectrum of terbium chelate has several sharp and well-separated peaks and 
valleys. This quality was exploited when terbium chelate (conjugated to an antibody 
that could recognize the receptor) was used as a single donor for two different 
acceptors (fluorescein and Alexa Fluor 633 conjugated to two different peptides) 
simultaneously. Based on whether the receptor had bound to the target ligand or not, 
one of the two peptides could bind to the receptor surface and, thus, close enough for 
FRET to occur. During measurement, the wavelength of the sensitized emission of the 
acceptor could indicate the presence or absence of the ligand-protein-interaction. 
(Kupcho et al., 2007.)   
The sandwich assay technique is usually impropriate when small analytes (haptens) are 
to be measured, due to the fact that two antibodies cannot bind to haptens 
simultaneously. Therefore, haptens are typically measured using competitive assays 
where the analyte competes of the binding sites of the recognizing agent with a labelled 
analyte analogue (Figure 12, II). The conjugation of the label to the analyte can be 
achieved using different methods. For example, the analyte could be conjugated to 
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bovine serum albumin (BSA) molecule together with europium chelates to form a large 
donor molecule. Together with a Cy5 dye labelled T3 thyroid hormone specific 
antibody, a homogeneous T3 assay was designed that had excellent correlation with a 
heterogeneous RIA. (Wang et al., 2006.) More universal donor complexes can be 
created with terbium chelate labelled streptavidin. The antigen analogue was 
biotinylated and, thus, capable of binding to the terbium-streptavidin complex. This 
time Cy-labelled herbicide specific antibody was used as an acceptor complex. With 
this protocol the number of donors participating to the energy transfer was increased 
compared to a conventional antigen-label complex and the assay was able to reach the 
performance of generally used HPLC method.  (Wang et al., 2001.) Hapten assays can 
also be non-competitive. For example, Cy5 labelled antibody recognizing immuno- 
complex of another antibody (labelled with europium chelate) and morphine was used 
to design a non-competitive homogeneous assay. To further improve the assay, 
antibody Fab fragments were used to reduce the amount of futile donor and acceptor 
molecules too far to participate in FRET and, thus, only contributing to the level of 
background. With this protocol a detection limit of 5 ng/mL was achieved while the 
cut-off detection level of opiates in oral fluids is typically 40 ng/mL. (Pulli et al., 
2005.) However, the development of these anti-IC antibodies can be somewhat 
challenging. Also other than the conventional acceptors can be used. Hildebrandt et. al 
have shown that a terbium chelate could be used as a donor for CdSe/ZnS core shell 
quantum dots. With that system detection limit of 3.3 pM was achieved. (Hildebrandt 
et al., 2005.) However, the method was tested using biotin-streptavidin complex, which 
is based on very strong and highly stable interactions, thus the performance of an 
actual assay system should be evaluated before final conclusions. 
In addition to immunoassay detection, FRET can also be used in distance 
measurements. Lanthanide chelates can be synthesized to contain various reactive 
groups (such as thiols) and can, therefore, be labelled into specific sites of different 
biomolecules. Thus, the distance of the D-A pair can be controlled. These properties 
have been utilized in distance measurements, for example, when conformational 
changes in myosin (Xiao et al., 1998) and in AE1 protein from red blood cells (Knauf 
and Pal, 2004) were studied. Both of these applications used terbium chelate as a donor 
together with appropriate acceptors.   
Since homogeneous assays are typically very easy to perform, in ideal cases mix and 
measure assays, they are very appealing techniques to be used in high throughput 
screening (HTS) applications in pharmaceutical industry when new, potential drug 
compounds are searched. Commonly, these applications study whether the target 
molecule has some effect to a specific biological incident, for example 
protease/nuclease activity. In these enzyme activity assays, the substrate is typically 
labelled with both donor and acceptor. If the enzyme cleaves the substrate, the donor 
and acceptor end up too far from each other for FRET to occur. (Figure 12, IV) 
Karvinen et. al has used this principle to create different enzyme activity assays for 
caspase, helicase and phosphatase. All of these assays were based on removing the 
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quencher molecule from the proximity of the lanthanide chelate donor via enzyme 
activity. When europium chelate was used as a donor, some remarkably high 
quenching efficiencies were obtained (99.97% with QSY7 as an acceptor/quencher). It 
was also shown that the D-A pair optimisation is essential since the different assays 
showed best energy transfer properties with different quenchers, even though donor 
was europium chelate in every assay. Thus the energy transfer distance and the ionic 
environment around the donor and acceptor had an effect to the performance of 
different D-A-pairs. (Karvinen et al., 2004b.) Similar principle was also used to 
multiplex caspases 1, 3 and 6. In that research, the substrates were labelled with 
samarium, terbium or europium chelates together with appropriate quenchers. Since the 
emission peaks of the different lanthanide chelates are sited at different wavelengths 
(see page 21, figure 7), the emissions could be measured simultaneously. Thus, the 
assay was able to detect the activity of a mixture of the three enzymes in the same well. 
(Karvinen et al., 2004a.) Another caspase assay utilized a universal donor (streptavidin 
coated europium nanoparticles) together with Alexa Fluor 680 and BlackBerry 
quencher conjugated to the substrate. When the substrate was intact, the energy could 
first transfer from europium particle to Alexa Fluor 680 and from there to the 
BlackBerry. Thus, double FRET occurred. If the substrate was cleaved, there was no 
energy transfer from Alexa to BlackBerry, thus no quenching happened, and the 
emission of the Alexa Fluor could be measured. (Valanne et al., 2008.) Enzyme 
activity assay can also be based on acceptor emission measurement. Kinase assay was 
developed where energy transfer from terbium chelate (conjugated to a 
phosphospecific antibody) to either fluorescein or green fluorescent protein could only 
happen if the substrate was phosphorylated by the kinase.  Since GFP can be used as a 
fusion protein, this assay principle enables the screening of GFP fusions of native, 
physiologically relevant substrates. (Riddle et al., 2006.) Important issue to consider, in 
these activity assays, is the distance between the D-A pair. The flexibility of the 
different substrates vary, thus in truth the donor and the acceptor could be much closer 
to each other than theoretically seems. If the true distance of D-A pair is small relative 
to R0, the energy transfer might be too rapid to be efficiently measured using the 
typical parameters of lanthanide chelates for time-resolved measurements. Thus, the 
performance of the assay might be improved if the D-A distance is increased. (Vogel 
and Vedvik, 2006.) On the other hand, it has been shown that with extremely short D-
A pair distance together with high efficiency FRET and a very short delay time before 
the measurement the sensitivity of the assay can be improved (Laitala, 2005). 
However, these systems require very sophisticated instrumentation.       
Also HTS assays that measure small analytes have been developed, for example, 
competitive estradiol assay that utilized FRET between antibody-coated europium 
particle and estradiol-Alexa Fluor 680. Compared to conventionally labelled antibody 
as a donor, the particle-based assay achieved 20 times better sensitivity. (Kokko et al., 
2004, Kokko et al., 2008.) Protein-protein interactions might provide a feasible base 
for HTS assays. Glaser et. al have published an assay that could screen molecules that 
might affect the growth of different bacteria. In that research, two proteins, crucial for 
Review of the Literature 
 
  32 
 
 
the survival of the bacteria (Escherichia coli), were labelled with terbium chelate or 
Cy3 dye. If any of the screened substances prevented the complex formation of these 
two proteins, no FRET could occur. (Glaser et al., 2007.) The combination of europium 
chelate as a donor and APC as an acceptor has inspired couple of research groups to 
develop different HTS applications. They have been used to create a screening assay 
for small-molecule inhibitors of HIV-1 fusion and possibly the viral entry (Dams et al., 
2007). Also, a small-molecule inhibitors of ubiquitination, and thus possibly 
modulators of the turnover of growth-regulatory proteins, have been screened with 
Eu/APC pair. When this assay was compared to a conventional heterogeneous assay, 
the performance of the homogeneous assay was slightly inferior but the homogeneous 
assay had better precision. (Boisclair et al., 2000.)  In addition, this D-A pair was used 
to screen molecules that affect ligand interactions to herpes virus entry mediator 
receptor. This assay principle was functional in 384-well format, which makes it 
particularly useful in HTS studies. (Moore et al., 1999.)  
FRET can also be utilized to create homogeneous DNA hybridisation assays where the 
objective is to detect the target DNA in solution without immobilization of the DNAs 
or separation of the reaction solution. The assays are typically based on two DNA 
probes, labelled with donor or acceptor, and each being complementary to two 
different regions of a target DNA. The chosen probes are in close proximity and FRET 
can happen between the D-A pair if the target DNA is present. (Figure 12, III) 
Hybridisation assays can be used, for example, in gene expression analysis or in 
diagnosis of infectious and genetic diseases. Mathis has used the previously described 
europium cryptate/APC pair to create a DNA hybridisation assay that had equivalent 
analytical sensitivity but better capturing efficiency and speed than a corresponding 
heterogeneous assay (Mathis, 1995). Sueda et. al utilized the benefits of using multiple 
labels as donor complex to create two DNA hybridisation assays using either europium 
or terbium labelled streptavidin as the universal donor. The probes where conjugated to 
either biotin or appropriate Cy-dye. With these assays, detection limits for the target 
DNA were 200 pM and 30 pM using europium or terbium, respectively. (Sueda et al., 
2000, Sueda et al., 2002.) It is also possible to create a DNA hybridisation assay using 
only one probe labelled with both donor and acceptor (europium chelate and Alexa 
fluor 647 or 700). In this assay the coiling of the unhybridised probe brought the donor 
and acceptor in very close proximity resulting very high intensity acceptor signal with 
a short lifetime. When the probe was hybridised to the target DNA, the distance of the 
D-A pair increased and the lifetime and the intensity of the acceptor emission were 
changed. (Laitala et al., 2007.) All of the previously presented applications were based 
on the Förster principle of the spectral overlapping of the D-A pairs. However, it has 
been shown that lanthanide chelates can be used to create systems that do not fully 
comply with the Förster theory. Laitala and Hemmilä have shown that, sometimes, 
sensitized emission of the acceptor can be measured even if there is virtually no 
overlapping of the spectra, thus, this phenomenon is called non-overlapping i.e. 
nFRET. Using this technique with DNA hybridisation assay, quenching efficiencies of 
80-90% of the fluorescence of europium chelate were achieved even though the Förster 
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radii were only 3-5.5 Å. (Laitala and Hemmilä, 2005.) In addition to DNA 
hybridisation assays, FRET has also been used to improve lanthanide based RT-PCR 
application. In RT-PCR, the accumulation of the PCR product is read in real time; 
whereas in end point applications the results are measured only once after the PCR 
reaction has ended. Nurmi et. al have used an environmentally sensitive terbium 
chelate to design RT-PCR assays. The chelate was conjugated to the probe, which was 
cleaved by the nucleic acid polymerase during the amplification of the target DNA. 
Since the chelate was highly fluorescent only in solution and only mildly fluorescent 
when connected to the probe, the amplification of the DNA resulted increasing 
fluorescence of the terbium chelate. (Nurmi et al., 2000.) This technique was further 
improved by adding another oligonucleotide conjugated to a quencher (QSY7) 
complementary to the lanthanide-probe. Thus the fluorescence of the intact probe in 
the solution was quenched using the QSY-7-oligonucleotide. This enhanced the signal 
to background ratios and enabled detection of 100 copies of the mRNA, whereas with 
commonly used Taqman system (Applied Biosystems) 1000 copies were needed for 
similar detection. (Nurmi et al., 2002.)      
Some of the previously described D-A pairs and technologies have also been 
commercialised. LanthaScreen by Invitrogen utilizes a terbium chelate as a donor and 
fluorescein as an acceptor. The europium cryptate and APC applications using two 
different wavelengths during measurement are manufactured as Kryptor systems by 
Brahms. Europium and recently also terbium (Lumi4-Tb) cryptates are used in 
HTRF/TRACE assays together with appropriate acceptors by CisBio International (see 
also Mathis, 1999). In addition, Wallac, Perkin Elmer Life and Analytical Sciences has 
been active in creating homogeneous assay formats: The previously described 
quenching based enzyme activity assays are manufactured as TruePoint assays. 
Whereas the LANCE technology utilizes two different europium chelates together with 
appropriate acceptors (Hemmilä, 1999).  
In conclusion, it can be said that fairly many different types of FRET applications 
utilizing lanthanides as donors has been published. It appears that most of the 
applications are based on FRET between lanthanide chelates and organic dyes. 
However, it seems that excellent results are obtained with these pairs, thus their 
prevalence is somewhat justified. Based on the increasing number of publications in 
this area, the future prospects of the FRET applications, using lanthanides as donors, 
appear to be bright and exciting.        
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3 AIMS OF THE STUDY 
The aim of the present study was to research the donor properties of lanthanide 
chelates (europium and terbium) in FRET. By employing these properties, the 
possibilities of novel homogeneous assay techniques were explored.  
More specifically the aims were: 
I To study the appropriate acceptors for efficient quenching of fluorescence of 
europium(III) chelate. By using these quenchers, create a non-competitive 
homogeneous assay design for haptens employing biotin-streptavidin 
interaction as a model system. 
II To prove that the previously presented assay technique (I) can be used in an 
actual non-competitive homogeneous assay for hapten (E2). Also the 
interference of the biological matrix (human serum) to FRET was studied. 
III To study the possibility of using terbium(III) chelate as a single donor for 
multiple wavelength acceptors. For this, the performance parameters of the 
competitive E2 assay using various acceptors were determined together with 
interference measurements between different acceptors. 
IV To create an actual homogeneous dual-parameter assay for free and total PSA 
utilizing terbium(III) chelate as a single donor together with two acceptors and 
to study the possibility of using the assay technique with actual human samples 
(lithium-heparin plasma). 
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4 SUMMARY OF MATERIALS AND METHODS 
In this chapter, an overview of materials and methods is given. More detailed 
information about materials and methods can be found in the original publications (I–
IV).  
4.1 Measurement of fluorescence and sensitized emissions 
Both the fluorescence of the lanthanide chelates and the sensitized emission of the 
fluorescent dyes were measured using time-resolved fluorometry. The fluorescence of 
the europium(III) and terbium(III) chelates was measured with 1420 Victor Multilabel 
Counter (Perkin Elmer Life and Analytical Sciences, Boston MA) using protocols 
installed by the manufacturer. The excitation wavelength for both chelates was 340 nm 
and the emission filters were 615 nm and 545 nm for europium(III) and terbium(III) 
chelates, respectively. Both of the lanthanide fluorescence measurements had delay 
time of 400 µs and measurement time of 400 µs.  
The sensitized emissions of Alexa Fluor (AF) 488, 555, 595 and 680 were measured 
using 1420 Victor Multilabel Counter with appropriate emission filters (Table 1). For 
the measurement of the emission of AF 680 a red-sensitive R4632 photomultiplier tube 
was used (Hamamatsu Photonics, Shimokanzo, Japan). (IV)  
Table 1 The emission filters for the fluorescent dyes 
Fluorescent dye       Emission, nm          Manufacturer 
AF 488   520  Chroma Technology Corp. (Rockingham, VT) 
AF 555   572  installed by instrument manufacturer 
AF 594   615  installed by instrument manufacturer 
AF 680   720  Coherent Inc. (Santa-Clara, CA) 
In addition, for the measurement of the sensitized emission of AF 680 a modified 1234 
Delfia Research Fluorometer (Wallac, Perkin Elmer Life and Analytical Sciences) with 
a red-sensitive R2949 photomultiplier tube (Hamamatsu Photonics) was used. (III) For 
all the measurements, the delay time was 75 µs and the measurement time was either 
400 µs (III) or 50 µs (IV). 
4.2 Conjugation of proteins to lanthanide chelates 
For the study, various protein molecules were labelled with lanthanide chelates. 
Streptavidin (I, Societa Prodotti Antibiociti, Milan, Italy) and E2 specific antibody Fab 
fragment (II, produced and purified as described by Kokko et al., 2004) were labelled 
with intrinsically fluorescent europium(III) chelate (2,2’,2’’,2’’’-{[2-(4-
isothiocyanatophenyl) ethylimino]-bis(methylene)bis{4-{[4-(α- galactopyranoxy) 
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europium(III)) (von Lode et al., 2003). E2 specific antibody Fab fragment (III) and 
PSA specific Mab 5E4 (IV) were labelled with intrinsically fluorescent terbium(III) 
chelate (2,2’2’’,2’’’-{{6,6’-{4’’-[2-(4-isothiocyanatophenyl)ethyl]-1H-pyrazole-
1’’,3’’-diyl} bis(pyridine)-2,2’-diyl}bis(methylenenitrilo)]tetrakis(acetato) 
terbium(III)) (Rodrigues-Ubis et al., 1996). 
For the labelling reactions 160 to 480 µg of protein and 5 to 100 molar excess of 
lanthanide chelate dissolved in water was used. The pH was adjusted to 9.8 by adding 
carbonate buffer (final concentration of 50 mM). Reactions were incubated over night. 
The next day, reactions were purified using size separation with gel filtration. The 
amount of protein in the purified products was determined by absorbance measurement 
at 280 nm, and the amount of the lanthanide chelate was defined by comparing the 
fluorescence of the product to the fluorescence of a known standard.  
4.3 Conjugation of acceptors 
During this research, a selection of various fluorescent and non-fluorescent organic 
dyes was used as acceptors (Table 2).   
The appropriate dyes were selected based on the overlapping of their absorption 
spectra with the emission spectra of the donors together with either their quenching 
properties (I and II) or their fluorescence properties (III and IV). Acceptors were 
conjugated to amino-modified biotin (I, N-(2-Aminoethyl)biotinamide, Molecular 
Probes Inc, Eugene, OR), amino-modified estradiol (II and III (Mikola and Hänninen, 
1992)) or PSA specific antibodies H50 and 5A10 (IV (Piironen et al., 1998)).  For the 
conjugation, 10 to 100-fold molar excess of the organic dye was used. The pH of the 
reactions was adjusted to 9.0-9.3 by adding carbonate buffer. The reactions were 
incubated for 4 hours in +37 ˚C and either frozen until purification (I-III) or purified 
immediately (IV). The small molecule conjugates (I-III) were purified using reversed-
phase HPLC technology (Instrumentation from Thermo Electron Corp. Waltham, MA) 
with Genesis C18 column (Jones Chromatography, Grace Vydac, Hesperia, CA). 
Gradient purification was done using 50 mM triethylammonium acetate (TEAA, Fluka 
Biochemica, Steinheim, Switzerland) in water or in acetonitrile. The antibody-acceptor 
conjugates (IV) were purified with gel filtration using NAP5 and NAP10 columns (GE 
Healthcare, Chalfont St Giles, UK). The amounts of the acceptor dye in the purified 
products were defined by absorbance measurements (appropriate wavelengths provided 
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Table 2 Physical characteristics of the acceptor dyes provided by the manufacturers. 













 1/(cmM) Manufacturer 
Dabcyl 366 454 --a 32700 
Molecular Probes,  
Invitrogen 
(Carlsbad, CA) 
Atto612Q 888 615 -- 114000 
ATTO-TEC 
(Siegen, Germany) 
QSY7 791 560 -- 84300 
Molecular Probes,  
Invitrogen 
(Carlsbad, CA) 
QSY9 951 562 -- 88200 
Molecular Probes,  
Invitrogen 
(Carlsbad, CA) 
QSY21 815 661 -- 89600 
Molecular Probes,  
Invitrogen 
(Carlsbad, CA) 
Cy5 792 649 670 250000 
GE Healthcare 
Chalfont St Giles, 
UK 
Cy7 818 747 776 200000 
GE Healthcare 
Chalfont St Giles, 
UK 
Alexa Fluor 
488 643 495 519 71000 




555 ~1250 555 565 150000 




594 820 590 617 90000 




680 ~1150 679 702 184000 
Molecular Probes,  
Invitrogen 
(Carlsbad, CA) 
      
a) non-fluorescent dye 
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4.4 Efficiency of FRET 
4.4.1 Quenching efficiency 
The efficiency of the energy transfer was estimated by comparing the fluorescence of 













FQ                                                                                             (3) 
 
Where FDA is the fluorescence intensity of the donor in the presence of the acceptor and 
FD is the fluorescence intensity in the absence of the acceptor. (Lakowicz, 1999) 
4.4.2 The Förster radii 
The theoretical efficiency of the energy transfer was estimated by calculating the 
Förster radii for the different donor-acceptor pairs.  
 
[ ] 6/1420 )(211.0 λκ JQnR D−=                                                                                      (1)                   
where  




=                                                                                          (4) 
Where J is the spectral overlapping of the D-A pair (see figure 2, page 1 ); κ is a factor 
describing the relative orientation in space of the transition dipoles of the donor and the 
acceptor; n is the refractive index of the medium; QD is the quantum yield of the donor; 
FD(λ) is the corrected fluorescence intensity of the donor and εA(λ) is the extinction 
coefficient of the acceptor. (Lakowicz, 1999.) 
4.5 Model analytes 
In this research, two different homogeneous assay principles were developed. Both of 
these principles needed an appropriate model analyte, in order to test the performance 
of actual assays. In this chapter, the analytes are introduced briefly. 
For the non-competitive hapten assay, 17β-estradiol (E2) was selected as the model 
analyte. E2 is a small molecule (~270 MW) and the most important female sex 
3
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hormone. It regulates the female menstrual cycle as well as maintenance of the bone 
mass and cardiovascular system for both genders. Normal E2 levels vary according to 
age and menstrual cycle. In diagnostics, E2 levels are used, for example, when 
monitoring hormonal infertility treatment, assessing ovarian function or diagnosing 
tumors. It has also been shown that increased amounts of E2 and its metabolites 
stimulate the proliferation of cancer cells. Therefore, the pharmaceutical industry uses 
E2 assays in high throughput screening while searching for a proper inhibitor for E2 
synthesis in cancer cells (Kokko et al., 2005). Due to human activity, E2, and other 
estrogens, are also found in many aquatic environments from where they can be carried 
into aquatic animals. This external E2 can cause several serious problems to water 
animals, such as abnormal sexual development (Guillette et al., 1994) or induced 
vitallogenin production in male trout (Tanaka et al., 2004). Thus, analyzing E2 from 
environmental samples is of growing importance. 
Prostate-specific antigen (PSA) is a member of the human kallikrein protease family 
(Yousef and Diamandis, 2002). PSA is produced by prostatic epithelial cells (Henttu et 
al., 1992) and occur mainly complexed to α1-antichymotrypsin (65-95% of the total 
PSA in blood).) Some of the PSA (5-35%) is present in free, uncomplexed, form. (Lilja 
et al., 1991, Stenman et al., 1991.) It has been shown that the ratio between total PSA 
and free PSA is less in cancer cases than in benign prostatic hyperplasia (Christensson 
et al., 1993). Thus, there is a diagnostic demand to measure both free and total PSA 
from a single sample. Furthermore, PSA has multiple epitopes and a large variety of 
different monoclonal antibodies have been developed for these epitopes. This makes 
PSA a good candidate as a model analyte in the homogeneous dual-parameter assay. 
Typically, healthy young men (<45 years) have PSA levels of less than 1 ng/mL. PSA 
values correlate strongly with age because benign prostate enlargement with increasing 
age will increase PSA concentration in blood (Preston et al., 2000). Therefore, the 
upper limits for suggested reference ranges in men are 2.5, 3.5, 4.5 and 6.5 ng/mL for 
ages 40-59, 50-59, 60-69 and 70-79 years, respectively (Oesterling et al., 1993).    
4.6 Homogeneous assay protocols 
All the developed assays in this research were homogeneous assays based on FRET. A 
summary of the assay specifications is presented in table 3 (page 41). More detailed 
instructions can be found in the original publications.  
The developed assays had either competitive or non-competitive nature. In this thesis, 
non-competitive assay is defined as an assay that measures directly the amount of 
analyte. Thus, the signal is created by those complexes containing the analyte and, 
therefore, the amount of signal increases when the concentration of the analyte 
increases. Whereas in competitive assays the amount of analyte is measured indirectly 
and the measured signal is created by complexes that do not contain any analyte. 
(Instead, the analyte is replaced by analyte-analogue conjugated to an acceptor.) Thus, 
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the amount of signal decreases when the concentration of the analyte increases. To 
conclude, the key difference between the basic assay techniques is not the presence or 
absence of competition but the origin of the measured signal. 
A schematic picture of the fundamental principles underlying the developed assays is 
presented in Figure 13. If the assay principle was based on quenching (I, II), the FRET 
between donor and acceptor decreased the donor emission in proportion to the analyte 
amount. When fluorescent dye was used (III, IV), the amount of sensitized acceptor 
emission could be measured if the recognizing agent had bound the acceptor-conjugate. 
Thus, the amount of sensitized emission was either decreasing (III) or increasing (IV) 
with the analyte concentration. 
 
Figure 13 Basic principles underlying all the developed assays. Left: If the donor (Ln3+) and 
the acceptor (A) complexes are bound together either directly (I-III) or via analyte as a 
sandwich complex (IV), FRET can occur. Thus, the emission of the lanthanide chelate is 
decreased (I, II) or in the case of fluorescent dyes, sensitized emission of the acceptor can be 
measured (III, IV). Right: If the donor-binder complex is not bound to the acceptor–conjugate, 
no FRET occurs. Thus, there is no sensitized emission and the emission of the lanthanide 
chelate is not inflected. 
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5 SUMMARY OF RESULTS AND DISCUSSIONS 
Summary of the results and discussions of the original publications and some 
unpublished data are presented in the following section. 
5.1 Components of the homogeneous assays 
5.1.1 Protein-lanthanide chelate donors 
In all of the developed assays, proteins labelled with intrinsically fluorescent 
lanthanide chelates acted as donors. The emission spectra of the used lanthanide 
chelates (europium(III) and terbium(III)) are presented in figure 14.  
Figure 14 Time-resolved emission spectra of the intrinsically fluorescent terbium(III) chelate 
(dashed line) and europium(III) chelate (solid line). 
For both chelate donors, the labelling degrees (lanthanide chelates per protein 
molecule) were determined by measuring the protein amount with absorbance 
measurements. The amount of lanthanide chelate was measured by comparing the 
fluorescence of the labelled product to the fluorescence of a known lanthanide 
standard. Usually several labelling reactions were done and the product with the most 
suitable labelling degree was chosen for further studies. The obtained labelling degrees 
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Table 4 The labelling degrees of the donors used in the research.  
Donor   Labelling degree  Original publication 
SA-Eu   3.2, 4.2 and 6.3    I 
FabS16-Eu  1.7a     II 
FabS16-Tb  4.0     III 
Mab 5E4-Tb  12.4     IV 
aAfter the gel purification some free europium(III) chelate was detected in the purified product. 
Therefore, fractions were dialyzed in order to remove the remaining free label. 
5.1.2 Selection of the acceptors 
In order to FRET to occur, short distance between the donor and the acceptor as well as 
spectral overlapping between the emission of the donor and the excitation of the 
acceptor are required (Förster, 1948). There are wide selection of different fluorescent 
and non-fluorescent dyes that can act as acceptors. Thus, the appropriate acceptors for 
each of the studies were selected based on the features required by the assay principle.  
For the development of the non-competitive homogeneous assay for hapten (I and II), 
the key factor was the acceptors ability to quench the fluorescence of the europium(III) 
chelate. Thus, the absorbance spectrum of the acceptor needed to overlap well with the 
emission spectrum of europium(III) chelate (Figure 15). 
Figure 15 The absorbance spectra of the appropriate quencher dyes for europium(III) chelate 
(solid line) from left to right: Dabcyl (dotted line), QSY9 (dash dotted line), Atto612Q (dashed 
line), QSY21 (dash dot dot line), Cy5 (short dashed line), Alexa Fluor 680 (short dash dot line), 
Cy7 (short dotted line). 
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When the possibility to use terbium(III) chelate as a single donor in a homogeneous 
multiplex assay was studied (III and IV), the fluorescence properties of the acceptors 
were dominating factors. The chosen acceptors had emission maxima at the emission 
valleys of the terbium(III) chelate. Minimum spectral overlapping between the 
acceptors was also required. (Figure 16) 
Figure 16 Emission spectra of the fluorescent dyes suitable as acceptors for terbium(III) chelate 
(solid line), from left to right: AF 488 (dotted line), AF 555 (dashed line), AF 594 (dash dot 
line), AF 680 (dash dot dot line).  
In most of the assay applications, it was possible to conjugate only one organic dye per 
acceptor component (I-III). In these cases, the fractions from the purifications were 
characterized and fractions containing both the organic dye and the antigen were 
selected. For the homogeneous PSA assay (IV) monoclonal antibodies were 
conjugated with organic dyes. The labelling degrees for the free PSA (F-PSA) specific 
Mab5A10-AF488 and total PSA (T-PSA) specific MabH50-AF680 were 13.9 and 5.4, 
respectively.  
5.2 Efficiency of FRET (I, III) 
The theoretical efficiency of energy transfer between donor and acceptor can be 
estimated by calculating the Förster distance for the pair. Föster radius is the distance 
between donor and acceptor at which FRET is 50% efficient. Typically, the Förster 
radii are 20 to 90 Å. The longer the Förster distance of the donor-acceptor pair the 
more efficient is the energy transfer between them. (Lakowicz, 1999.) 
Summary of Results and Discussions 
 
  45 
 
 
The Förster radii were calculated for both of the donors (europium(III) chelate and 
terbium(III) chelate) with various acceptors (Table 5) using equations presented in 
4.4.2. Since all the measurements were performed in aqueous solution, the refraction 
index (n) was 1.33. The κ2 is a factor describing the relative orientation in space of the 
transition dipoles of the donor and acceptor. It is usually assumed to be equal to 2/3, 
which was used in these calculations as well. It has been previously reported that this 
assumption can produce only ±35% error in the calculated distances. (Lakowicz, 
1999.) The quantum yields of the donors were 0.127 for europium(III) chelate (von 
Lode et al., 2003) and 0.42 for terbium(III) chelate (Rodrigues-Ubis et al., 1996). The 
observed efficiency of energy transfer can be estimated by calculating the amount of 
donor emission quenched by FRET. The higher the quenching efficiency the more 
efficient the energy transfer is.  
Table 5 Calculated Förster radii and the observed quenching efficiencies for the donor-acceptor 
















Dabcyl 9.3 90 AF 488 46 29 
Atto612Q 56 98 AF 555 61 52 
QSY9 36 97 AF 594 53 46 
QSY21 53 95 AF 680 52 42 
Cy5 56 67    
Cy7 47 96    
AF 680 57 78    
a Approximately half of the antibody Fab fragment used in the tests was found to be inactive 
and thus not capable of binding the antigen. Therefore the maximum attainable quenching 
efficiency was ~60%.  
Since the selection of the suitable acceptors was based on spectral overlapping of the 
emission spectra of donors and the absorption spectra of acceptors, the theoretical 
Förster radii were very similar with all the pairs. However, the Förster distance of the 
europium(III)-Dabcyl pair was very short. Nevertheless, Dabcyl was able to quench 
nearly 90 % of the emission of the Eu(III) chelate. Similar results have been obtained 
also previously and Dabcyl has been successfully used as an acceptor with europium 
chelate by others as well (Karvinen et al., 2002, Gopalakrishnan et al., 2002). This 
could be a consequence of intramolecular collisions. If the distance between the 
quencher and the fluorophore is short enough for relatively high frequency of 
collisions, effective depression of the fluorescence might occur. (Yaron et al., 1979.) 
Streptavidin is relatively small molecule (~60000 MW) with four binding sites, thus 
the donor label and Dabcyl molecule could be close enough proximity for collisions. In 
conclusion, the non-fluorescent quencher dyes (Dabcyl, Atto612Q, QSY9 and QSY21) 
were the most effective at quenching the donor emission. 
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In the case of Tb(III) chelate, the selected acceptors were distributed more evenly 
through the emission spectrum of the donor (Fig. 16). However, the acceptor AF 555 
(absorption spectrum covering most of the emission spectrum of Tb(III) chelate) had 
the longest Förster distance and also attained the highest quenching efficiency and, 
thus, had the most efficient energy transfer. In conclusion of the fluorescent dyes as 
acceptors for Tb(III) chelate, the observed results were perfectly in line with the 
calculated theoretical Förster distances.  
The most efficient quenchers for Eu(III) chelate were also examined by using titration 
curve (Figure 17). For this study, SA-Eu(III) complex that had a labelling degree 
around four was selected. Streptavidin has four binding sites for biotin and the 
biotin/acceptor proportion was one, thus, when all SA-binding sites were occupied 
there was roughly one acceptor per one Eu(III) chelate.  
Figure 17 Titration of the quenching efficiencies of the Eu(III) chelate- acceptor pairs: QSY9 
(■), Atto612Q (●) and CY7 (▲). 
In order to obtain maximum quenching of the Eu(III) chelate emission 1.25-fold excess 
of Cy7 or QSY9 and 1.6-fold excess of Atto612Q quenchers per binding site of 
streptavidin was needed. In the case of one quencher being able to completely quench 
the fluorescence of one Eu(III) chelate, the theoretical quenching efficiency at 5 nM 
quencher concentration  would have been around 30%. However, the observed 
quenching efficiencies were significantly higher. Since the quenching efficiency is 
relative to the distance between the D-A pair, the fluorescence lifetime of those Eu(III) 
chelates that were close to the quencher were diminished completely. The fluorescence 
lifetime of those chelates that were further from the quencher dye were only somewhat 
decreased and, thus, some fluorescence could still be measured. In conclusion, 
according to these results one quencher can affect the fluorescence of more than one 
Eu(III) chelate. Similar results have also been presented by Karvinen, 2004.  
Summary of Results and Discussions 
 
  47 
 
 
5.3 Cross-talk between acceptors (III) 
In order to see whether the terbium(III) chelate could successfully be used as a single 
donor for multiple acceptors (AF 488, AF 555, AF 594 and AF 680) simultaneously, 
the cross-talk between different acceptors was tested. This was performed by 
measuring the sensitized emissions of each acceptor at all the measurement 
wavelengths (520, 572, 615 and 720 nm). The results were calculated as percentage of 
the emission of the interfering acceptor from the emission of the right acceptor for the 
given wavelength. Results of these cross-talk measurements are presented in table 6. 
Table 6 Amount of interference compared to the signal of the theoretically suited acceptor. 
    Measurement wavelength 
Acceptor  520 nm  572 nm  615 nm  720 nm 
AF 488   --a  10%  n.d.b  n.d. 
AF 555   n.d.  --  9%  2% 
AF 594   n.d.  n.d.  --  19% 
AF 680   n.d.  n.d.  n.d.  -- 
a The measurement wavelength of the acceptor 
b Non-detectable, the percentage was less than 0.1% 
At the measurement wavelength of 520 nm, no interference from the other acceptors 
was detected. In the case of 572 and 615 nm, the acceptors with emission maxima at 
lower wavelengths caused slight interference (~10%). The highest cross-talk was from 
AF 594 when measured at 720 nm. In fact, due to the very low background from donor 
emission at that wavelength, the signal to background ratio of AF 594 was higher at 
720 nm (S/B=15) than at 615 nm (S/B=6). This indicates that if AF 594 is to be used as 
an acceptor for terbium(III) chelate, the longer measurement wavelengths (from 700 
nm up) are more appropriate, even though the emission maximum of the acceptor is at 
~617 nm. In conclusion, it appears that the cross-talk between different acceptors can 
be controlled by selecting the acceptors carefully.  
The possibility to use AF 488 and AF 680 simultaneously was studied using 
competitive homogeneous E2 assay. First the assays were performed with E2 
calibrators using one of the acceptors. After the incubation and just before the 
measurement, other solution containing Tb(III)-Fab and AF 680 or 488-E2 was added. 
(If AF 488 was used in the actual assay then AF 680 was used now and vice versa.) 
Thus, during the measurement the situation in the wells mimicked a dual-parameter 
assay, where the concentration of one analyte changes between wells and the other 
creates maximum interference to the measurement. The obtained standard curves for 
both acceptors are presented in figure 18. As can be seen, the standard curves for both 
single and simultaneous measurements are almost identical with both acceptors. Only a 
slight increase in the signal of the higher calibrators was observed, which slightly 
inflicted the range of the assays.  
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Figure 18 Standard curves from the homogeneous single (filled circles) and simultaneous 
(filled squares) measurements with cv-profile (hollow symbols) when using left: AF 488 and 
right: AF 680 as acceptors. The ranges of the single and simultaneous measurement assays are 
illustrated with dashed and dotted lines, respectively. (III) 
Based on these results, it can be concluded that terbium(III) chelate can act as a single 
donor for multiple acceptors and the acceptors can be measured simultaneously 
without interfering cross-talk, provided that the acceptors were chosen appropriately. 
This also means that it could be possible to create a homogeneous multi-parameter 
FRET assay based on Tb(III) chelate as the donor and AF 488 and AF 680 as 
acceptors. 
5.4 Performance of the developed homogeneous assays (I-IV) 
5.4.1 Non-competitive assay for hapten (I, II) 
Haptens are low molecular weight antigens, e.g. many drugs, steroids, metabolites and 
polluctants that are too small to be recognized simultaneously by two binders (for 
example antibodies). Therefore the developed assays for haptens are typically 
competitive assays, where the analyte to be measured competes with labelled analyte 
analogue for the binding sites of a single recognizing agent. However, due to the 
difference in the principles of the non-competitive and competitive assays (see chapter 
2.1), the non-competitive assays are considered to have better sensitivity than 
competitive assays. (Saviranta, 2000.) Sensitivity is typically defined as the smallest 
amount of analyte that generates a distinguishable difference from the background 
signal (Ekins and Edwards, 1997, Ekins and Edwards, 1998). With non-competitive 
assays the signal level at zero calibrator is low, whereas with competitive assay it is 
high. It is considered to be more accurate to measure small changes in low signals than 
in high signals, thus non-competitive assay principles are regarded to be inherently 
more sensitive than competitive assays. 
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The developed homogeneous non-competitive assay principle was based on the 
quenching of europium(III) chelate using FRET and non-fluorescent dyes. First the 
assay principle was tested using biotin (analyte) – streptavidin (binder) as a model 
system (I). After the pre-testing, an actual homogeneous non-competitive assay was 
created for E2 using antibody Fab fragment as a binder (II). In both of these systems, 
the interaction between the analyte and the binder was strong and dissociation slow 
(Wilchek and Bayer, 1990, Lamminmäki et al., 2003). Therefore they were appropriate 
models for this principle, where one of the key features is the ability of the binder to 
clench to the analyte. The binder was labelled with europium(III) chelate and the 
analyte analogue conjugated to the non-fluorescent acceptor. First, the analyte to be 
measured and the Eu(III)-binder were let to interact with each other. Thereafter, the 
acceptor-analyte was added, thus it could bind to those binders that were still free from 
the analyte. During the measurement, FRET quenched the emission of those Eu(III)-
binders that were bound to analyte-acceptor conjugates. Thus, the emission was created 
by those Eu(III)-binders that were bound to the measured analyte. Therefore, the signal 
increased when the amount of analyte increased. Thus the assay had a non-competitive 
nature.  
For the biotin assay, three different quenchers were used as acceptors (QSY9, Cy7 and 
Atto612Q). Standard curves and kinetics of the assays are presented in Figure 19. 
Figure 19 Left: Standard curves with standard error bars of the homogeneous non-competitive 
assay with different quenchers; QSY9 (■), Cy7 (●) and Atto612Q (▲). The dotted lines 
indicate the detection limits of the assays: 500, 200 and 250 pM for QSY9, Cy7 and Atto612Q, 
respectively. (I) Right: The kinetics of biotin-quencher incubation indicated as the quenching 
efficiencies at different time points. (Unpublished results) 
One streptavidin has four binding sites for biotin. Furthermore, one quencher can 
quench the fluorescence of more than one chelate. Thus, rather significant increase in 
biotin concentration was required to alter the signal levels. Also, the proportion of the 
change in the signal level to the change in the concentration was not linear, and 
therefore the standard curves were not linear either. (Equations for the assays were for 
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QSY9: y=2327x1.7, R2=0.85; Cy7: y=5005x1.4, R2=0.99 and Atto612Q: y=3372x1.5, 
R2=0.98; unpublished data.) However, the kinetics of the assays were very fast. All the 
assays reached the maximum quenching efficiency within five minutes. Another, 
somewhat similar, homogeneous assay for biotin has been published. In that assay, the 
biotin replaces the quencher molecule from labelled avidin, thus the signal level 
increases with increasing biotin concentration. However, due to the replacement step, 
the lowest measurable concentration was only about 40 nM. (Batchelor et al., 2007.) In 
conclusion, it was shown that a homogeneous non-competitive assay based on the 
quenching of the donor emission could be created for hapten. 
The actual hapten assay was created for E2 using europium(III) chelate as a donor and 
non-fluorescent QSY21 as an acceptor. Also the other, previously presented, acceptors 
were tested but the QSY21 gave the best results within this assay. The standard curves 
for the E2 assay using buffer and serum-based calibrators are presented in Figure 20. 
Figure 20 Standard curves for the E2 assays with standard error bars and cv-profile (●). Lowest 
limits of detection illustrated with dotted lines. Left: using buffer based calibrators 
(y=172000x1.02, R2=0.994). Right: using human serum-based calibrators (y=38000x1.03, 
R2=0.963). (II) 
Since Fab fragments are monovalent, both of the assays gave linear response. The 
lowest limits of detection were 18 pM (4.9 pg/mL) and 64 pM (17 pg/mL) with buffer 
calibrators and serum calibrators, respectively. The performance of the buffer 
calibrator assay was tested against a homogeneous competitive assay utilizing the same 
components with AF680 as an acceptor conjugated to amino-modified E2 (for further 
information see II). The obtained competitive assay had a lowest limit of detection at 
1.2 nM, thus the non-competitive assay had 67 times better detection limit than the 
competitive assay. Since the Förster radii for QSY21 and AF 680 were almost similar 
(see table 5), the efficiencies of the energy transfer could assumed to be similar in both 
assay principles. Therefore, the improvement of the detection limit was most likely a 
consequence of the non-competitive nature of the designed assay. Zhao et al. have 
developed a heterogeneous competitive assay for E2 using enzymatical signal 
amplification attaining detection limit of 5.4 pg/mL (Zhao et al., 2006). Thus, the 
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homogeneous non-competitive assay had equal performance, even though 
heterogeneous assays are generally regarded as more sensitive than homogeneous 
assays (Blomberg et al., 1999). However, when the same E2 specific Fab fragment was 
used to create a competitive heterogeneous assay, detection limit of 8 pM was attained 
(Lamminmäki et al., 2003). Thus, when the same binder was used, the heterogeneous 
competitive assay performed better than the homogeneous non-competitive assay. 
When serum calibrators were used, the detection limit increased 3.5 times from the 
detection limit of the buffer calibrators. This is most likely due to the endogeneous 
steroid binding proteins in serum, which impair the usability of E2 assays with serum 
samples (Brock et al., 1978, Slaats et al., 1987, Masters and Hahnel, 1989). Therefore, 
Mesterolone was added to the buffer to block these proteins. Mesterolone improved the 
reproducibility and decreased dispersion but had no effect to the detection limit. For 
further discussion of the matrix effect to FRET based assays see chapter 5.5.1.  
Since the maximum attained quenching efficiency was only 50-60%, the properties of 
the Fabs16 were studied. The functionality of the Fab was tested using either 
streptavidin coated wells together with biotinylated estradiol or anti-mouse IgG coated 
wells. The results showed that only ~50% of the Fab was capable of binding to 
estradiol compared to the anti-mouse IgG treated wells. Thus, for some, reason a 
substantial amount of Fab was inactive and only contributing to the background signal. 
In conclusion, a homogeneous non-competitive assay with very good detection limit 
was demonstrated. However, due to the presence of inactive Fab fragment, the acceptor 
was able to quench only approximately 50% of the donor emission. Thus by improving 
the quenching efficiency, to be precise by removing the inactive binder, even more 
sensitive assay could be created. 
5.4.2 Homogeneous antibody assay (Unpublished) 
The homogeneous hapten assay could be reversed to create a homogeneous antibody 
assay. In this assay principle, the binder was labelled with non-fluorescent acceptor and 
analyte analogue was conjugated to europium(III) chelate. E2 specific Fab fragment 
was used as a model antibody. First, the antibody to be measured was let to bound with 
E2-Eu(III). Thereafter, the Fab-Atto612Q was added and it was let to interact with 
those E2-Eu(III) that had not bound to the measured antibody. Thus, during the 
measurement emission of those E2-Eu(III) that are bound to Fab-Atto612Q is 
quenched and only the emission from antibody-E2-Eu(III) complexes could be 
measured. The obtained standard curve is presented in Figure 21. 
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Figure 21 Standard curve of the homogeneous antibody assay with standard error bars. The 
detection limit is presented with dotted line (y=440x0.91, R2=0.98, detection limit 2.2 ng/mL). 
(Unpublished results) 
The slope of the curve was rather small, thus increase of the antibody concentration 
created only small increase in the signal. This is, however, understandable since each 
of the antigenes can be conjugated to only one europium(III) chelate. Also the 
maximum quenching efficiency of the system was surprisingly low at 30%. Thus, the 
background of the assay was high, which impaired the lowest limit of detection. The 
low quenching efficiency was most likely due to the poor stability of the Fab fragment. 
Furthermore, the labelling with the non-fluorescent dyes requires the use of organic 
solvents, which presumably deteriorated the functionality of the Fab fragment even 
further. In fact, Atto612Q-Fab was the only quencher complex that could provide some 
quenching. The other tested quenchers apparently destroyed the activity of the Fab 
completely and, thus, no quenching was observed. However, the presented assay 
principle could be used to measure antibody concentration in situations where the 
sensitivity of the assay is not the key factor, for example during antibody production or 
purification.  
5.4.3 Competitive homogeneous assay for E2 (III) 
The homogeneous competitive E2 assay has been published previously by Kokko et 
al., 2004. In this work, the E2 assay was used to study the donor properties of the 
terbium(III) chelate; more precisely the possibility of using the localized emission 
valleys of the terbium(III) chelate to create homogeneous assays. The tested acceptors 
were AF 488, 555, 594 and 680 (for spectra, see Fig. 16). The obtained standard curves 
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Figure 22 The standard curves with standard error bars for the homogeneous competitive 
assays using I: AF 488; II: AF 555; III: AF 594 and IV: AF 680 as acceptors. The practical 
ranges of the assays are presented with dashed lines. (Unpublished) 
As can be seen, with all of the acceptors a standard curve for E2 was obtained. The 
lowest measurable concentration was ~300 pM for all of the assays. The highest 
measurable concentration varied from 3.3 to 5.6 nM. Signal to background ratios were 
24, 11, 6 and 45 for AF 488, AF 555, AF 594 and AF 680, respectively. Thus the 
performances of the assays were rather similar, even though there were differences in 
the S/B ratios. In conclusion, all of the four emission minima of the terbium(III) 
chelate could be used to create a homogeneous assay. 
5.4.4 The Homogeneous dual-parameter assay for PSA (IV) 
Due to the overlapping of the emission spectra of the different lanthanides (see figure 
7), developing a homogeneous multiplexed assay based on the measurement of the 
sensitized emission of the acceptors has been challenging. Since the emission maxima 
of the different lanthanides encompass the entire measurement area, selecting the 
appropriate measurement wavelengths could be difficult. However, previously it has 
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been shown that terbium(III) chelate can be used as a single donor for multiple 
acceptors (III, (Kupcho et al., 2007)). Total PSA (PSA-T) and free PSA (PSA-F) were 
used as model analytes to create an actual homogeneous dual-parameter assay where 
the sensitized emission of the acceptors is measured. PSA is an excellent model analyte 
for this type of assay principle because PSA has multiple epitopes (Nurmikko et al., 
2000) and a large variety of PSA specific antibodies exists. The developed assay was 
based on FRET between terbium(III) chelate (labelled to PSA-T specific antibody) and 
two fluorescent acceptor dyes AF 488 and AF 680 (conjugated with PSA-F specific 
and PSA-T specific antibodies, respectively). Therefore, if PSA-F was present in the 
sample FRET could happen between terbium(III) chelate and AF 488 and sensitized 
emission could be measured at 520 nm. The amount of PSA-T could be determined 
from the sensitized emission of AF 680 at 720 nm. Thus, the assay could 
simultaneously measure the amount of both PSA-F and PSA-T. To study the possible 
interactions of the acceptors to each other, the assays were also performed as 
homogeneous single-parameter assays containing only one of the acceptors at time. 
The standard curves for the assays were performed using a recombinant PSA, which 
does not form complexes and, thus, remained in PSA-F form. (Rajakoski et al., 
1997)(figure 23).  
Figure 23 Standard curves for the homogeneous single (■) and dual-parameter (●) assays  for 
Left: PSA-F and Right: PSA-T. The lowest limit of detection of the dual-parameter assay is 
illustrated with dotted lines. (IV) 
 
As can be seen, the performance of the homogeneous dual-parameter assay was almost 
identical with the performance of the single-parameter assays. The analytical 
sensitivities (3 times the standard deviation of the background) for PSA-F and PSA-T 
were 0.74 ng/mL and 0.60 ng/mL, respectively. The highest calibrator still in the linear 
range was 100 ng/mL for both assays. The maximum obtained signal to background 
ratios (using 200 ng/mL calibrator) were 12 and 10 for PSA-F and PSA-T, 
respectively. The equations of the homogeneous dual-parameter assays were: 
y=998x0.90 (R2=0.999) for PSA-F assay and y=195x0.83 (R2=0.997) for PSA-T assay.  
The kinetics of the dual-parameter assay were relatively fast. When a 50 ng/mL 
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calibrator was used, the PSA-F assay had reach over 80% of the signal level within 10 
min. PSA-T assay was slightly slower and reached the 80% signal level in 30 min. The 
performance of the homogeneous dual-parameter assay for PSA-F and PSA-T was 
comparable to the previously published heterogeneous dual-parameter assays 
(Leinonen et al., 1993, Mitrunen et al., 1995). 
5.5 Limiting factors of the developed assays (II, IV) 
5.5.1 Matrix effects (II, IV) 
Due to the nature of the homogeneous assay principles, the sample is present during 
the measurement. Therefore, the sample matrix, especially biological matrixes e.g. 
human plasma and serum, can cause interferences to the assay results by, for example, 
interacting with the fluorescent label (Mathis, 1993). When lanthanide chelates are 
used as donors in homogeneous assays, whole blood cannot be used as a sample 
matrix. This is due to the fact that whole blood has a strong absorption of light at the 
ultraviolet region where the excitation of the lanthanide chelates also occur. Thus, the 
matrix prevents the excitation of the donor. (Kuningas et al., 2005.) However, other 
biological matrixes could be viable. In this research, the homogeneous non-competitive 
E2 assay principle was tested using spiked male serum and the homogeneous dual-
parameter assay for PSA-F and PSA-T was tested using spiked female heparin plasma.  
As can be seen in figure 20, the performance of the E2 assay was somewhat poorer 
when serum based calibrators were used. The lowest limits of detection were 18 pM 
and 64 pM for buffer and serum calibrators, respectively. The matrix effect to the 
actual FRET process was studied by adding un-spiked serum to the wells shortly 
before measurement. Therefore, serum could only affect FRET during the 
measurement and not interfere with the antigen antibody interactions during the 
incubation. In that experiment, the obtained signal levels for 5% and 10% serum 
additions (percentage of the serum in total well volume) were 98% from signal with no 
serum. Thus, the serum addition did not interfere with FRET measurement. Instead, the 
deterioration of the performance with serum calibrators was most likely due to the 
steroid binding proteins, which interfere with the interaction of E2 and antibody (Brock 
et al., 1978, Slaats et al., 1987, Masters and Hahnel, 1989). 
Different situation prevailed when PSA assay was tested with spiked plasma samples. 
Plasma absorbs within the area where the FRET between terbium(III) chelate and AF 
488 or AF 680 occurs. (Figure 24, left) Especially, the strong absorption between 300 
nm and 500 nm could mean significant interference for the PSA-F assay (AF 488). 
Also the absorbance spectrum of the assay buffer was measured but the absorbance 
values were less than 0.04 between the area of 300 nm to 750 nm.   
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Figure 24 Left: The absorbance spectrum of 10% lithium-heparin plasma in water. 
(Unpublished) Right: The correlation of homogeneous dual-parameter assay with 
heterogeneous single-parameter assay using spiked plasma samples for PSA-F (square) and 
PSA-T (circle). Equations for the original results (filled symbols): PSA-F 0.46x+0.91 
(R2=0.994) and PSA-T 0.66x+0.33 (R2=0.997). Equations for the corrected results (hollow 
symbols): PSA-F 0.73x+1.43 (R2=0.994) and PSA-T 0.93x+0.46 (R2=0.997). (IV and 
unpublished results) 
 
When the performance of the homogeneous dual-parameter assay was tested against 
heterogeneous single-parameter assays, the effect of the plasma was clearly seen. 
(Figure 24, right) The results of the homogeneous assay were consistently lower than 
the results of the heterogeneous assay and as speculated earlier, the PSA-F results were 
poorer than PSA-T results. The effect of the plasma to FRET was estimated similarly 
than in the case of E2 by adding 10% plasma in to the wells shortly before 












Where the S(X ng/mL(10%)) were sensitized emission signals from the wells that 
contained 10% plasma and the other values were results from wells that contained only 
buffer. Using these coefficients (0.6 for PSA-F and 0.7 for PSA-T) the results were 
corrected (Figure 24, right, hollow symbols). After the correction the slopes of the 
curves improved, especially with PSA-T. Thus the absorbance of the plasma explained 
some of the deviations. However, even after the correction, the homogeneous assay 
still generated somewhat lower results than the heterogeneous assays. Despite these 
differences, the correlations of the homogeneous dual-parameter assay versus the 
heterogeneous single-parameter assays were good. In the review of literature, it was 
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shown that the sample interference can be decreased by using dual wavelength 
detection where both donor and acceptor emission is measured (Mathis, 1993). 
However, dual-wavelength concept is not feasible with this assay principle, since either 
one or two acceptors are gaining energy from the donor. The number of acceptors 
present during measurement depends on the ratio of PSA-F and PSA-T, thus the 
influence of the energy transfer to the donor emission varies with the sample 
composition.       
5.5.2 Hook effect (IV) 
The Hook effect occurs when a high excess of antigen saturates both capture and tracer 
antibodies, thus preventing the formation of detectable capture-antigen-tracer 
complexes (for example Wild, 2005). The Hook effect is a common problem especially 
within tumour markers since their concentration can vary from low to very high values 
(Basuyau et al., 2001). In the developed homogeneous dual-parameter PSA assay, all 
the antibodies are present simultaneously, thus the principle is susceptible to Hook 
effect. The severeness of the Hook effect was tested using high PSA concentrations. 
The obtained sensitized emissions and the calculated concentrations are presented in 
figure 25.  
Figure 25 Hook effect studies using high PSA concentrations. Left: The measured sensitized 
emissions of the acceptors for different spiked PSA concentrations. Right: The calculated PSA 
concentrations from the sensitized emissions. (Unpublished) 
The signal levels of both assays started to decrease after 200 ng/mL. However, when a 
very high PSA concentration (1000 ng/mL) was used, the calculated concentrations 
were ~60 ng/mL and ~25 ng/mL for PSA-T and PSA-F, respectively. Thus, the signal 
levels were still clearly elevated from the background level and above the clinically 
important cut off levels. It also appears that the Hook effect decreased the results of 
PSA-F more than the results of PSA-T. On the other hand, the amount of PSA-F in 
blood is small compared to PSA-T, thus the Hook effect might eventually be more 






















































































During the past view decades FRET has gained popularity as the starting point for 
designing various homogeneous assays. Even though these techniques are 
predominantly based on energy transfer between two organic dyes, also lanthanide 
chelates have previously been used as donors due to their many beneficial 
characteristics. In this study, the objective was to design novel immunoassays that 
utilize those features.  
The conclusions based on the original publications are: 
I: When europium(III) chelate labelled streptavidin was used as a donor complex and 
biotin-organic dye as an acceptor to quench the fluorescence, quenching efficiencies  
up to 98% were achievable. Furthermore, one quencher dye molecule was able to 
quench the fluorescence of more than one europium(III) chelate. For maximal 
quenching 1.25 to 1.6–fold excess of the dye per streptavidin binding site was needed. 
It was also shown that a non-competitive assay can be designed using the quenchers 
and lanthanide chelates, even though the performance of the biotin assay was 
somewhat compromised by the quadrovalent nature of the streptavidin as a binder. 
This, together with the high quenching efficiency, deteriorated the linearity of the assay 
since the proportion of the response to the changing biotin concentration was not 
straightforward. However, this research provided a good foundation for the 
development of an actual homogeneous non-competitive assay for hapten. 
II: The previously studied donor/quencher characteristics were utilized to develop the 
homogeneous non-competitive assay for 17β-estradiol. The assay was based on 
europium(III) chelate labelled antibody Fab fragment (the donor complex) and QSY21 
conjugated to amino-modified estradiol (the acceptor/quencher complex). With this 
system, the maximum obtained quenching was unexpectedly only ~55%. This was 
found to be due to the presence of inactive Fab fragment, which was not capable of 
binding estradiol and, thus, only contributed to the background of the assay. However, 
even with this defect the assay principle was able to detect 18 pM concentrations of 
estradiol, which was 67 times better detection limit than with corresponding 
conventional competitive homogeneous assay. Furthermore, due to the monovalent 
binder, the response was impeccably linear with exponent of the equation of the 
standard curve at 1.02. However, it can be speculated that if the quenching efficiency 
could be improved further, the sensitivity of the assay might be even better. The 
developed assay principle can be applied to other haptens as well, provided that a high 
quality antibody (with low dissociation rate and good affinity) is available.  
III: Terbium(III) chelate has several sharp emission peaks with clear emission minima 
between them. The possibility to use terbium(III) chelate as simultaneous, single donor 
for different acceptors emitting at the emission valleys was studied using conventional 
homogenous competitive assay for estradiol. Signal to background ratios from 6 to 45 
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were obtained; the major cause for the variation being the background from the 
terbium chelate emission. Furthermore, the obtained quenching efficiencies followed 
the theoretically calculated Förster radii perfectly. All of the tested acceptors could be 
used to create a functional estradiol assay. The leakage of the acceptor emission to the 
other measurement wavelengths was observed to be small; and, mainly, from the 
acceptor emitting closest at the smaller wavelengths. Thus, based on these results, the 
terbium chelate could potentially act as a single donor for multiple acceptors emitting 
at different wavelengths, provided that the acceptors are selected accordingly. 
IV: The possibility to use terbium(III) chelate as a single donor for two acceptors 
simultaneously was studied  by designing a homogeneous dual-parameter 
immunoassay for free and total PSA.  The two acceptors did not interfere with each 
other and the performance of the dual-parameter assay was identical with the 
performance of corresponding homogeneous single parameter assays. Both free and 
total PSA was measurable using clinically important concentrations. The typical 
disadvantage of the homogeneous assays was observed when the performance of the 
assay was tested against heterogeneous single parameter assay; the sample material 
(plasma) interfered with the energy transfer and, thus, impaired the functionality 
compared to the heterogeneous assays. However, the correlation of both free and total 
PSA was good, even though the obtained concentrations were slightly less than with 
the heterogeneous assays. Furthermore, the developed assay had very simple protocol 
(mix and measure) and it is adaptable to other analytes that should preferably be 
measured simultaneously from one sample.   
To conclude, it is possible to stretch the current applications of lanthanide chelates in 
FRET further and find new ways to design assay principles. The superior fluorescence 
characteristics of lanthanides (e.g. long lifetime, large Stokes’ shift and narrow 
emission peaks) enable them to overcome many of the problems encountered by other 
donors (such as autofluorescence of the background or direct excitation of the 
acceptor) and contribute to the development of ever better assays. In this research, the 
sensitivity of hapten immunoassay was improved by designing a non-competitive assay 
format. In addition, the simultaneous measurement of total and free PSA was eased 
with a homogeneous, dual-parameter assay format. 
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